The document provides an overview of the pharmaceutical industry in India. Some key points:
- The Indian pharmaceutical sector accounts for about 2.4% of the global pharmaceutical industry in value and is expected to grow at a CAGR of 12.89% to reach $55 billion by 2020.
- India accounts for 20% of global exports in generics drugs. Exports were $16.4 billion in 2016-17 and are expected to grow 30% to $20 billion by 2020.
- Generic drugs form the largest segment of the Indian pharmaceutical market, accounting for 70% of the market. Anti-infectives represent the largest therapeutic segment.
The document discusses India's advantages in low-
Indian pharmaceutical industry supplies over 50% of global demand for various vaccines and drugs. It is expected to grow at 22.4% annually to reach $55 billion by 2025. India accounts for 20% of global exports in generics. The domestic market is expected to reach $27.9 billion by 2020 with high potential for growth in generics. Increased investment in R&D and acquisitions are driving growth in the robust Indian pharmaceutical sector.
The document provides an overview of the pharmaceutical industry in India. Some key points:
- India is a major global player in pharmaceuticals, accounting for around 3% of the global industry. The market is expected to grow to $55 billion by 2020 and $100 billion by 2025.
- India has a large generics market and is a major exporter, accounting for 20% of global exports. Exports were $16.84 billion in 2016-17 and are projected to reach $20 billion by 2020.
- Key segments of the market include generics, Active Pharmaceutical Ingredients, Contract Research and Manufacturing Services, and biosimilars. Anti-infectives represent the largest segment dome
This is a very good presentation on Indian Pharmaceutical sector prepared by India Brand Equity Fund ( IBEF ) working under Commerce Ministry, Govt of India. A very good effort is made to cover all aspects of Indian pharma.They could have included ABLE also.
Industry CEOs can consider to use this ppt in overseas presentations.
Indian pharmaceutical industry is the third largest in terms of volume and is expected to grow to US$ 55 billion by 2020. It supplies over 50% of global demand for various vaccines and HIV/AIDS medicines. India accounts for 20% of global exports in generics. Exports stood at US$ 17.27 billion in FY18 and are expected to reach US$ 20 billion by 2020. The domestic market is expected to reach US$ 27.9 billion by 2020. India has a competitive advantage due to its low cost of production which is approximately 33% lower than the US. The government aims to make India a global leader in drug manufacturing through initiatives like 'Pharma Vision 2020'.
The Indian pharmaceutical sector is estimated to reach $100 billion by 2025, accounting for 10% of the global pharmaceutical industry by volume. It currently accounts for 20% of global generic exports. The sector is expected to grow at a CAGR of 12.89% until 2020 to reach $55 billion. By 2020, India will be among the top 3 pharmaceutical markets by growth and 6th largest globally. The government has implemented policies and initiatives like 'PharmaVision 2020' to make India a global pharmaceutical leader and improve affordability and availability of medicines.
The document provides an overview of the pharmaceutical industry in India. Some key points:
- The Indian pharmaceutical industry is expected to grow at a CAGR of 12.89% until 2020 to reach $55 billion in size.
- India accounts for 20% of global exports in generics drugs. Exports stood at $16.84 billion in 2016-17 and are expected to reach $20 billion by 2020.
- The domestic pharmaceutical market was worth $27.57 billion in 2016 and is estimated to have grown 7.4% to $29.61 billion in 2017. The market is expected to continue growing rapidly over the next few years.
Indian pharmaceutical sector accounts for about 2.4% of the global pharmaceutical industry in value terms and 10% in volume terms. The country's pharmaceutical industry is expected to expand at a CAGR of 12.89% over 2015–20 to reach US$ 55 billion, making it among the fastest growing industries. India exports 20% of global exports in generics, with pharmaceutical exports at US$ 16.8 billion in 2016-17 and projected to reach US$ 20 billion by 2020. The generics market stood at US$ 26.1 billion in 2016 with high potential for growth. By 2024-25, India's biotech industry is estimated to increase to US$ 100 billion from US$ 11 billion in FY 2015
Indian pharmaceutical sector is estimated to account for 3.1-3.6% of the global pharmaceutical industry in value terms and 10% in volume terms. The country's pharmaceutical industry is expected to expand at a CAGR of 12.89% over 2015-2020 to reach US$ 55 billion. India accounts for 20% of global exports in generics. By 2020, India is likely to be among the top three pharmaceutical markets by incremental growth and 6th largest market globally in absolute size. The generics market stood at US$ 26.1 billion in 2016 and has high potential for growth. By 2024-25, India's biotech industry is estimated to increase to US$ 100 billion from US$ 11 billion in F
The document provides an overview of the pharmaceutical industry in India. Some key points:
- The Indian pharmaceutical industry is expected to grow to $55 billion by 2020, expanding at a CAGR of 12.89% from 2015-2020.
- India accounts for 20% of global exports in generics, with pharmaceutical exports at $16.84 billion in 2016-17, expected to reach $20 billion by 2020.
- The biotech industry in India is also growing rapidly, estimated to increase from $11 billion in 2015-16 to $100 billion by 2024-25.
The document provides an overview of the Indian pharmaceutical industry. It notes that the industry is expected to grow to $100 billion by 2025, making India one of the top global markets. Currently valued at $27.57 billion, the industry is growing at 12.89% annually and exports over $16 billion worth of drugs globally each year. The generics market and biotech sector also have strong growth potential. The industry benefits from low production costs, a large skilled workforce, and government support for further development.
India's oil and gas sector is dominated by state-owned companies. India is the third largest energy consumer globally and its energy demand is expected to double by 2035. Oil consumption has expanded at a CAGR of 4.78% during 2007-2017 to reach 4.69 million barrels per day in 2017, with India retaining its spot as the third largest oil consumer. Gas consumption has increased at a CAGR of 3.40% between 2007-2017 and demand is projected to further rise significantly by 2040. The country increasingly relies on imports to meet its growing demand for oil and gas.
The document provides information on trends in the Indian pharmaceutical sector. It notes that Indian pharmaceutical companies are increasing spending on research and development to develop new drugs. Exports of pharmaceutical products from India have grown significantly in recent years and are expected to exceed USD15 billion in 2015, as Indian companies have a strong presence in the generics market. The top four pharmaceutical firms in India by revenue - Dr. Reddy's, Lupin, Cipla and Aurobindo - account for over 20% of the domestic market share. Anti-infective drugs represent the largest segment of the Indian pharmaceutical market. Exports and domestic sales have increased the size of the Indian pharmaceutical market to USD36.7 billion in 2016.
The document provides an overview of the pharmaceutical industry in India. Some key points:
- The Indian pharmaceutical industry is expected to grow at a CAGR of 12.89% until 2020 to reach $55 billion in size.
- India accounts for 20% of global exports in generics drugs and exports were $16.8 billion in 2016-17, expected to reach $20 billion by 2020.
- The generics market in India stands at $26.1 billion in 2016 and has strong growth potential.
- Major segments of the pharmaceutical industry in India include active pharmaceutical ingredients, formulations, biosimilars, and contract research and manufacturing.
IMS - Global Use of Medicines 2020 by Nitesh BheleNitesh Bhele
By 2020, global medicine use will reach 4.5 trillion doses, a 24% increase from 2015 levels. Over half of the world's population will consume over 1 dose per person per day, driven by increased access in large emerging markets like India, China, Brazil, and Indonesia. Developed markets will continue to use more branded and specialty medicines per capita, while emerging markets will see greater use of generics and over-the-counter drugs. New medicines introduced in the past 10 years will account for 0.1% of volumes in emerging markets versus 2-3% in developed markets.
This document discusses how the global healthcare profit pool will shift between 2010 and 2020. It predicts that the total profit pool will grow at 4% annually from $520 billion to $740 billion over this period. However, profitability will decline for most players as the sources of growth and margins change significantly between sectors and regions. Innovative pharmaceutical and medical technology companies will see much slower growth and declining margins. In contrast, providers of healthcare delivery and lower-margin sectors like generics will capture a larger share of profits. To remain competitive, companies will need to develop new business models focused on improving healthcare delivery and outcomes rather than just generating more products and procedures.
Advantages of Pharma in India, Market Share and Economic Drivers, Structure of Pharma Sector, Evolution of Pharma, Revenue %, Market Share, Porter 5 Force Model, BCG Matrix, Government Policies, Opportunities.
The document discusses the Indian pharmaceutical industry. It notes that expenditure on pharmaceuticals as a percentage of total healthcare spending is expected to increase significantly from 28% in 2007 to over 40% by 2015. This rapid growth will be driven by factors on both the supply and demand side. On the supply side, India has a strong competitive advantage in terms of low production costs. On the demand side, factors such as rising incomes, expansion of health insurance coverage, and a growing disease burden are expected to boost pharmaceutical consumption in India. The Indian pharmaceutical industry is well-positioned for continued strong growth over the coming years.
Indian Pharmaceutical Market Overview 2013 by Nitesh BheleNitesh Bhele
The document summarizes the Indian pharmaceutical market in 2013. It highlights that the Indian market was valued at around $10 billion and was expected to grow double digits in the next five years. The generic drugs market was estimated to make up around 90% of the prescription drug market by 2016. It also provides an overview of the key segments of the Indian pharmaceutical market, the largest global companies, top therapeutic classes and products, as well as government initiatives to support industry growth.
The document discusses the Indian pharmaceutical industry. It notes that India accounts for about 1.4% of the global pharma industry by value but 10% by volume. The industry is growing rapidly and is expected to reach $36 billion by 2016, expanding at a CAGR of 17.8%. India has a large and growing generics market, low-cost production, and government policy support promoting the pharmaceutical sector. The industry has significant export potential and is a major supplier of generic drugs globally.
The document provides an overview of the pharmaceutical sector in India. It discusses key trends in the Indian pharmaceutical market including growing demand, cost advantages, policy support, and a diversified product portfolio. It also outlines the structure and evolution of the pharmaceutical industry in India. The generics market is the largest segment and anti-infectives lead in terms of market share. Exports are a major focus and have grown significantly in recent years. The top firms invest heavily in R&D and account for over 20% of the domestic market.
The document provides an overview of the pharmaceutical industry in India. Some key points:
- India supplies over 50% of global demand for various vaccines and 40% of generic drugs in the US. The pharmaceutical sector was valued at $33 billion in 2017.
- Exports have grown significantly, reaching $17.27 billion in FY2018. The domestic market is also growing rapidly and is expected to reach $27.9 billion by 2020.
- Growth is driven by low production costs, a large skilled workforce, increasing healthcare spending, and a large generics market. The government is also supporting industry growth through initiatives like increasing FDI limits.
The document provides an overview of the pharmaceutical industry in India. Some key points:
- The Indian pharmaceutical industry is expected to grow at a CAGR of 12.89% until 2020 to reach $55 billion in size. India accounts for 20% of global generic drug exports.
- Major segments of the industry include active pharmaceutical ingredients, formulations, biosimilars, and contract research and manufacturing. Generics account for 70% of the domestic market.
- Leading therapeutic segments are anti-infectives, cardiovascular, and gastro-intestinal drugs. The biotechnology industry in India is also growing rapidly and is projected to reach $100 billion by 2025.
- Pharmaceutical exports from
The document provides information on the pharmaceutical industry in India. Some key points:
- India accounts for 20% of global pharmaceutical exports and the domestic market is expected to reach $55 billion by 2020, growing at a CAGR of 12.89% from 2015-2020.
- The generics market is the largest segment in India, accounting for 70% of the domestic market. India supplies 20% of global generic medicines by volume.
- Key growth drivers for the industry include low production costs, growing demand, policy support from the government, and a large/diversified product portfolio. The industry attracted 5% of total FDI into India from 2000-2016.
Pharmaceutical marketing in the 21st centuryRamdas Dolas
The document discusses the pharmaceutical industry in India. It notes that India supplies over 50% of global demand for various vaccines, 40% of generic demand in the US, and 25% of medicine in the UK, making it a leading pharma producer. The industry is growing rapidly at a 22.4% CAGR and is valued at $33 billion in 2017. India also accounts for 20% of global exports in generics, with exports reaching $17.27 billion in 2017-18. The domestic generics market is large as well and expected to reach $27.9 billion by 2020. The biotech industry is also seeing robust growth and estimated to reach $100 billion by 2024-25.
The document provides information on trends in the Indian pharmaceutical sector:
- R&D spending by major Indian pharmaceutical companies is increasing, with Sun Pharma spending the most at $352 million in FY16. Lupin expects R&D spending to be 12-15% of sales in FY17.
- Exports of pharmaceutical products from India have been rapidly growing and exceeded $16.89 billion in FY16, expected to reach $40 billion by 2020. Generic drugs account for 20% of global exports by volume.
- The top four pharmaceutical companies in India - Dr. Reddy's, Lupin, Cipla, and Aurobindo - captured over 20% of the
Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...Irish Pereira
By Mr. Irish Pereira. The report present snapshot of Indian Pharmaceutical industry in both domestic as well as export market. It is collation of facts pertaining to Indian pharma exports and explore key emerging trends pertaining to pharma export market. It describes key players of Indian pharma market and their export orientation as in their target export destinations, their focus therapies etc.
Fact sheet:
1) Indian Pharma Market size 2015
2) Indian pharmaceutical market segments by value
3)Patented (Innovator) Vs Generics Scenario
4)Growth drivers of Indian pharmaceutical industry
5) Indian Pharmaceutical sector – SWOT Analysis
6)PHARMEXCIL – Facilitating agency for Indian Pharma Exports
7) Indian Pharmaceutical Exports (USD bn)
8)Formulations share in Total Pharma Exports (2014-15)
9) Top 25 destination countries of India’s pharmaceutical exports during 2013-14 (INR mn)
10) Major Indian Pharma Companies (By Revenue-USD mn)
11) Pharma players and their export destinations
Sun Pharma,Dr. Reddy’s Lab,
CIPLA, Lupin, Aurobindo, Cadila Healthcare, Torrent Pharma, Wockhardt,
12) Emerging trends in Indian Pharma Market
- India is a leading producer of pharmaceuticals, accounting for around 2.4% of global pharma production by value and 10% by volume. It exports $16.89 billion worth of drugs annually.
- The Indian pharma market was worth $36.7 billion in 2016 and is expected to reach $55 billion by 2020, growing at a CAGR of 12.89%. Generics account for 70% of the domestic market.
- India has a large, diverse pharma industry with over 60,000 generic brands across 60 therapeutic categories. Production costs are much lower than in Western markets, boosting Indian competitiveness.
The document provides an overview of the pharmaceutical sector in India. Some key points:
- India accounts for 10% of global pharmaceutical production and 20% of global generics exports. Exports grew 9.44% in FY2016 to $16.89 billion.
- The domestic market was worth $27.57 billion in 2016 and is projected to reach $55 billion by 2020, growing at a CAGR of 12.89%. Generics account for 70% of the market.
- Major players include Dr. Reddy's, Lupin, Cipla and Aurobindo, who collectively account for over 20% of the market. Companies are increasing R&D spending to develop new drugs
The document provides an overview of the pharmaceutical industry in India. Some key points:
- India is a major global supplier of generic drugs, accounting for 20% of global exports. The pharmaceutical industry is expected to grow to $55 billion by 2020 from $27.57 billion in 2016.
- The industry benefits from low production costs, which are 60% lower than the US and half of Europe. Government policies also support the industry through initiatives like 'Pharma Vision 2020'.
- Generics account for 70% of the domestic pharmaceutical market. The largest segments by therapy are anti-infectives at 16%, cardiovascular at 13%, and gastrointestinal at 11%.
The document provides an overview of key trends in the Indian pharmaceutical sector:
- Indian pharmaceutical companies are increasing spending on research and development between 8-11% of total turnover to develop new drugs and boost sales.
- Pharmaceutical exports from India are thriving, particularly in generics, with exports exceeding $15 billion in 2015 and reaching $16.89 billion in 2016.
- Multinational companies are collaborating with Indian firms through joint ventures to develop new drugs, while Indian players are also expanding operations abroad.
The document provides an overview of the pharmaceutical sector in India. Some key points:
- India is a leading global producer of generic drugs and vaccines, accounting for 20% of global exports. The domestic market was worth $36.7 billion in 2016 and is forecast to reach $55 billion by 2020.
- The sector benefits from low production costs which are 60% lower than the US and half of Europe. Government policies also support the growth of the sector.
- Generics account for 70% of the domestic market, while chronic therapies like cardiovascular, anti-diabetic, and anti-infectives are major segments. Exports and domestic demand are driving continued expansion of the industry.
The document provides information on the pharmaceutical sector in India. Some key points:
- India accounts for approximately 10% of global pharmaceutical production and is the largest provider of generic medicines globally. Exports of pharmaceutical products from India reached USD 16.89 billion in FY2016.
- The domestic pharmaceutical market was worth USD 27.57 billion in 2016 and is expected to reach USD 55 billion by 2020, growing at a CAGR of 12.89% from 2015-2020. Generics account for 70% of the domestic market.
- Leading players like Dr. Reddy's, Lupin, Cipla and Aurobindo account for over 20% of the domestic market. Top companies are
The document discusses the Indian pharmaceutical industry and its advantages. It makes three key points:
1. The Indian pharmaceutical industry has grown significantly in recent decades and is now a major global supplier of generic drugs. It has over 700 member companies and exports over $12 billion worth of drugs annually.
2. India has many advantages that have fueled its pharmaceutical industry's growth, including a large skilled workforce, low production costs, and a large domestic market. It has received many regulatory approvals from agencies like the US FDA.
3. The growth of the Indian pharmaceutical industry has benefited global drug costs. As the largest producer and exporter of generic drugs, India has provided affordable treatment options and helped contain rising healthcare costs
Indian Pharma - An Overview by IDMA Secretary General Daara B PatelAnup Soans
This document discusses the Indian pharmaceutical industry and its growth opportunities. It notes that India is a major global supplier of affordable, high-quality medicines and has significant manufacturing capabilities and regulatory approvals. The Indian drug market is large and growing, fueled by increasing access, acceptance, and affordability of medicines in India. Indian companies are also major exporters and are collaborating with international partners. R&D investment is growing to develop new products and capture patent expiration opportunities.
The document provides an overview of the Indian pharmaceutical industry, including its history, growth, market structure, competition, exports and imports, and the effects of foreign investment. Some key points:
- The industry has grown significantly since its early years and now accounts for 8% of global pharmaceutical production.
- Major players include Ranbaxy, Dr. Reddy's Laboratories, Sun Pharmaceuticals, and AurobindoPharma.
- Exports have shown strong growth and now contribute around half of revenue for top companies. The US and Europe are major export markets.
- Foreign investment has impacted areas like new drug development, manufacturing standards, and marketing skills. Mauritius is a significant source of foreign
India is the largest producer of Generic drugs globally and a major supplier of vaccines. For India, this industry earns significant trade surplus and FDI. Let us talk about this industry.
Introduction to indian pharma industriespharmacampus
Introduction to Indian Pharma Industries: this highlights leading pharma producers, details of exports of medicines, growth statistics, and high potential generic market.
Similar to Pharmaceutical Sector Report July 2017 (17)
Tamil Nadu has a strong and growing economy, as evidenced by its GSDP which grew at a CAGR of 11.46% between 2011-12 and 2018-19, reaching Rs. 16.06 trillion (US$ 222.58 billion) in 2018-19. The state has a diversified industrial base and thriving services sector, especially in IT/ITeS. It also has robust infrastructure including roads, ports, airports, and an emphasis on further infrastructure development. With various initiatives like Vision 2023, Tamil Nadu aims to boost its economy and attract significant domestic and foreign investments over the coming years.
India has become the second largest steel producer in the world in 2018. Steel production and capacity in India have grown rapidly over the past decade, with capacity reaching 137.98 million tonnes in 2017-18. Consumption has also increased steadily, driven by growth in infrastructure, automotive, and other sectors. The government has implemented policies like the National Steel Policy to encourage further capacity growth to 300 million tonnes by 2030-31. Low per capita consumption compared to other countries also provides significant potential for further demand growth.
The document provides an overview of India's services sector, including:
1) The services sector contributes over 50% of India's GDP and grew at 12.75% in 2018-19, demonstrating its importance as the key driver of India's economic growth.
2) India has a large skilled workforce and is a global outsourcing hub, commanding a 55% share of the global sourcing market, which has helped establish the country as a leading provider of technology and digital services.
3) The government is working to further develop the services sector through initiatives like 'Startup India' and reforms that make India an attractive investment destination for both domestic and foreign investors.
The document provides an overview of the real estate sector in India. It discusses that the real estate sector is expected to reach $1 trillion by 2030 and contribute 13% of India's GDP by 2025. Rapid urbanization is driving demand for residential and commercial real estate space. The residential segment contributes around 80% of the sector currently. Government policies like Housing for All and Smart Cities are further boosting growth.
Rajasthan has experienced strong economic growth in recent years. Between 2011-12 and 2018-19, the state's Gross State Domestic Product grew at a compound annual growth rate of 11.37% to reach $128.1 billion. The tourism industry in Rajasthan is thriving, with over 47.5 million tourist arrivals in 2017, and the state is a leading producer of agro-based products. Rajasthan also has immense potential for renewable energy generation from solar and wind sources.
Indian Railways is the third largest rail network in the world by size. It saw strong revenue growth over the past decade, with freight accounting for over 65% of revenues in FY19. Freight and passenger traffic have both increased steadily in recent years. Various modernization initiatives are underway to upgrade infrastructure and technology. Private sector participation is being encouraged to augment rail connectivity and capacity.
India has the third largest installed power capacity in the world at 356.10 GW as of March 2019. It is the third largest producer and consumer of electricity globally. India has achieved 100% household electrification and aims to increase renewable energy capacity to 175 GW by 2022. Thermal energy accounts for over 63% of total installed capacity, while renewable sources account for 21.8%. The power sector in India is growing rapidly and offers many opportunities for investment and development.
Nagaland has a Gross State Domestic Product (GSDP) of around 0.24 trillion Indian rupees in 2017-18, growing at a CAGR of 11.83% between 2011-12 and 2017-19. The per capita GSDP in 2017-18 was 113,549 rupees, growing at a CAGR of 10.66% in the same period. Nagaland's Net State Domestic Product (NSDP) in 2016-17 was 0.19 trillion rupees, growing at 15.72% between 2011-12 and 2016-17. The per capita NSDP in 2016-17 was 90,168 rupees, growing at 12.
Meghalaya has the highest rainfall in India and diverse soil types that support agriculture. The state has strong potential in floriculture, bamboo processing, and medicinal plants due to its biodiversity. Meghalaya also has large hydroelectric power potential and abundant mineral resources. The state aims to promote industries like agro-processing, horticulture, minerals and tourism to create opportunities for its population.
- The Indian infrastructure sector is experiencing significant growth due to rising government investments and initiatives such as allocating Rs 4.56 lakh crore for infrastructure in the FY 2019-20 budget.
- Private sector participation is increasing across segments like roads, power and airports. Infrastructure sectors like power transmission and renewable energy will drive future investments.
- Improving connectivity through initiatives like Bharatmala Pariyojana and Sagarmala will boost infrastructure growth. 100% villages connectivity through roads is expected by 2019 under PMGSY.
The document provides an overview of the media and entertainment industry in India. Some of the key points from the document are:
- The Indian media and entertainment industry is growing rapidly at a CAGR of 12-13% and is expected to reach Rs. 3.73 lakh crore by 2022.
- Television is the largest segment with a market size of Rs. 740 billion in 2018, expected to reach Rs. 955 billion by 2021. Digital media, animation and VFX, and online gaming are among the fastest growing segments.
- Advantages for the industry in India include rising incomes, evolving lifestyles, a large young population, increasing digitization, and government support through
- The manufacturing sector is a major employer in India and aims to provide 25% of GDP and 100 million new jobs by 2022. It has grown at a CAGR of 4% between FY12-19 and contributes significantly to India's exports.
- The document discusses India's advantage in manufacturing including a large domestic market, favorable demographics, and government initiatives like Make in India. Key sub-sectors, growth drivers and the evolution of the sector are also outlined.
- Recent trends show growth in production, IIP, capacity utilization and exports, indicating the sector is expanding. The government has implemented various policies to develop manufacturing and make India a global hub.
Manipur has a flourishing bamboo processing industry as it is one of India's largest bamboo producing states. It also has a strong handicrafts industry, being home to the highest number of handicraft units and artisans in North East India. Handlooms is the largest cottage industry in Manipur. The state has strong potential for border trade opportunities through Moreh town, which is India's only land route for trade with Myanmar and Southeast Asia. Manipur is also home to the Ema Bazaar, one of India's largest markets run exclusively by women. Due to its natural beauty and biodiversity, Manipur is a popular tourist destination known as the "Switzerland of the East".
The document provides an overview of the economy of Himachal Pradesh, India. Some key points:
- Himachal Pradesh has a strong economic growth rate, with its GSDP reaching Rs. 1.52 trillion (US$21.04 billion) in 2018-19 growing at 11.09% annually.
- The state has a diverse economy with key sectors being tourism, agriculture, and hydroelectric power. Agricultural production and tourism visitor numbers are increasing.
- Himachal Pradesh has a large hydroelectric power potential and is becoming a major hub for hydroelectricity in India, though only around 40% of its potential has been harnessed so far.
Gujarat has experienced high economic growth rates in recent years.
- Gujarat's GSDP grew at a CAGR of 13.55% from 2011-12 to 2016-17, reaching Rs. 11.62 trillion (US$ 173.24 billion) in 2016-17.
- The state's per capita GSDP increased from Rs. 101,075 (US$ 2,108) in 2011-12 to Rs. 178,043 (US$ 2,654) in 2016-17, registering a CAGR of 11.99%.
The document provides an overview of India's gems and jewellery sector. Some key points:
- India is a major player in global gems and jewellery trade, contributing about 7% to India's GDP and employing over 4.6 million people.
- India is the world's largest cut and polished diamond exporter, exporting over 75% of global polished diamonds. It also processes over $23 billion worth of diamonds annually.
- Exports of cut and polished diamonds and gold jewellery have registered steady growth in recent years. Imports have also increased at a CAGR of nearly 8% between 2004-2018.
- The sector is adopting strategies like expanding retail networks, providing financing options
The engineering and capital goods industry in India is growing rapidly. The turnover of the capital goods industry reached $70 billion in 2017 and is forecasted to reach $115.17 billion by 2025. Electrical equipment production is also growing and is expected to reach $100 billion by 2022, up from $27.3 billion in 2017-18. The engineering research and design segment is also expanding, with revenues projected to increase from $28 billion in FY18 to $42 billion in FY22. Growth is being driven by increasing industrialization, infrastructure development, and capacity expansion across various core sectors in India.
Major e-commerce players in India have adopted strategies like expanding into new categories like groceries and used goods, acquiring analytics startups to improve pricing and positioning, and launching ancillary services like payments, logistics and video streaming. They have also introduced subscription models and personalized experiences to provide extra benefits and tailor their offerings to individual customer needs and interests.
Delhi has experienced strong economic growth, with its gross state domestic product increasing at a compound annual growth rate of 12.41% between 2011-12 and 2018-19. The real estate sector has been an important contributor to the state's economy. Delhi also has a growing tourism industry, owing to its historical and cultural attractions. The state government is working to improve infrastructure and implement policies to facilitate industrial development and attract investment across various sectors.
Chhattisgarh has a strong mineral production base and is a leading producer of coal and iron ore in India. It is the only state that produces tin concentrates. The state has emerged as a preferred investment destination and has witnessed strong growth in the agriculture sector. Key sectors driving growth include minerals, power, agriculture and tourism. Chhattisgarh aims to further develop its infrastructure, promote industries and boost skill development to achieve its vision of becoming an industrialized state.
Executive summary
• According to the IER estimates, in June GDP growth continued to decelerate: from 3.2% yoy in
May to 2.7% yoy in June - due to problems with access to electricity, which are the result of
damage to electricity generation by russian drones and missiles.
• The shortage of electricity remains very acute. Due to the uneven consumption during the day
peak hours, the deficit can reach 25-30%. Electricity imports have reached their maximum
capacity.
• Ukraine and the EU have extended the “transport visa-free regime” until 2025. In June, cargo
handling by seaports increased by 30% yoy to 6.7 m tons.
• Exports in June, according to customs, decreased significantly compared to previous months,
while imports remained almost unchanged compared to May.
• Expenditure performance deteriorated in June, most likely due to minimal external borrowing
in May and lower than expected external borrowing in June.
• In May, the Government received EUR 1.9 bn from the EU under the Ukraine Facility, but the
money from the IMF did not arrive until July.
• Ukraine fulfilled timely all the indicators of the Ukraine Plan, which were to be implemented by
the end of the 2nd quarter of 2024. Accordingly, the next tranche of the loan from the EU
should arrive in August.
• In June, inflation accelerated to 4.8% yoy due to higher electricity tariffs.
• The NBU is considering further key policy rate cuts in the second half of 2024.
• The hryvnia exchange rate exceeded UAH 41 per USD on the back of a high trade deficit and
high demand for cash currency.
how to successfully withdraw hamster tokens to TON - WALLETCRYPTO SPACE 🪙
Linking your wallet to Hamster Kombat for airdrop tasks is straightforward and rewarding...💰 It allows you to access special rewards and benefits within the game while deepening your engagement with the blockchain gaming community.
Players need to connect a consistent wallet like Ton Wallet to their Hamster Kombat account to manage their assets and participate fully in the game. This involves setting up the wallet, acquiring necessary tokens, and linking it to the game platform. Here are the steps to connect your wallet to Hamster Kombat.
Open the Hamster Kombat App or Website: Launch the Hamster Kombat application on your device or go to their official website.
Choose Your Wallet: You will be presented with several wallet options, including Tonkeeper, MyTonWallet, Tonhub, and DeWallet.
Connect Wallet: After setting up your Telegram account, you will see the option to “Connect Wallet.” Click on this option to connect your wallet and it will connect it to your Telegram account.
After successfully connecting your ton-wallet to hamster kombat, you have to consider waiting for the official launch and listing of Hamster Kombat tokens on reputable exchanges, ensuring a safe and secure trading experience...💪💱
"Meanwhile, if you don't have the patience to wait for Hamster Kombat's official launch...🐹, there's an even bigger opportunity you don't want to MISS...🔥 you can literally profit right now!...💯 and the best part is that it's not a crypto airdrop, mining or anything that requires you tapping or investing your time, energy and money.
It's a straight forward process and you can do it within minutes and get your own piece of the cake...💰
It's a secret crypto giveaway "NO" one is talking about.
I got $200 worth of BNB token From this crypto giveaway update in less than 24hrs here is how you can participate and earn today.
Go over to your browser now! and search 🔍 for "dailytrend247.com", it’s a legit crypto blog that is currently doing a secret crypto giveaway, Go check it out trust me, it’s 💯 legit and very easy to Join. 🏃🏃🏃
Immediately you enter the website click the "Learn>>>" button at the top of the first page
you'll be directed to the giveaway section.
Here is a 4 step process you can follow to successfully benefit.
Step 1: put your BNB wallet address, in other to receive the BNB reward.
Step 2: share to 5 friends, you need to invite your friends to join the giveaway 🎁
Step 3: Withdraw BNB 💰, at this point for you to get the free BNB you must "verify" by completing a simple survey or a sign up it depends on your region, the purpose of doing this is to actually know if you’re a human or robot, once done successfully you will get the BNB reward instantly to your crypto wallet.
BONUS TIP
To increase your chance getting the BNB reward I advise you should also join their community.
Also note the BNB reward may take a while before it arrive 👌
Thanks for reading...🙏
Has anyone made money from hamster kombat - the REAL truth.CRYPTO SPACE 🪙
Can I secretly sell my Hamster Kombat coins 🐹
As of now, Hamster Kombat tokens are not officially listed on any cryptocurrency exchange, and the project has not launched officially. Therefore, there is no legitimate way to sell Hamster Kombat tokens online.
Any claims of secret methods or unofficial markets promoting the sale of Hamster Kombat tokens should be approached with caution, as they may be potentially fraudulent or illegal. It's essential to prioritize security and avoid falling prey to scams or unauthorized activities.
Instead, consider waiting for the official launch and listing of Hamster Kombat tokens on reputable exchanges, ensuring a safe and secure trading experience. Remember, patience and caution are vital in the cryptocurrency space.
"Meanwhile, if you don't have the patience to wait for Hamster Kombat's official launch...🐹, there's an even bigger opportunity you don't want to MISS...🔥 you can literally profit right now!...💯 and the best part is that it's not a crypto airdrop, mining or anything that requires you tapping or investing your time, energy and money.
It's a straight forward process and you can do it within minutes and get your own piece of the cake...💰
It's a secret crypto giveaway "NO" one is talking about.
I got $200 worth of BNB token From this crypto giveaway update in less than 24hrs here is how you can participate and earn today.
Go over to your browser now! and search 🔍 for "dailytrend247.com", it’s a legit crypto blog that is currently doing a secret crypto giveaway, Go check it out trust me, it’s 💯 legit and very easy to Join. 🏃🏃🏃
Immediately you enter the website click the "Learn>>>" button at the top of the first page
you'll be directed to the giveaway section.
Here is a 4 step process you can follow to successfully benefit.
Step 1: put your BNB wallet address, in other to receive the BNB reward.
Step 2: share to 5 friends, you need to invite your friends to join the giveaway 🎁
Step 3: Withdraw BNB 💰, at this point for you to get the free BNB you must "verify" by completing a simple survey or a sign up it depends on your region, the purpose of doing this is to actually know if you’re a human or robot, once done successfully you will get the BNB reward instantly to your crypto wallet.
BONUS TIP
To increase your chance getting the BNB reward I advise you should also join their community.
Also note the BNB reward may take a while before it arrive 👌
Thanks for reading...🙏
Hamster kombat - A simple and effective method to withdraw mined tokens.CRYPTO SPACE 🪙
How to withdraw money from Hamster kombat:
Yes! you can withdraw your hamster tokens 🐹 by following the simple steps below:👇
Step 1: Earn money on Hamster Kombat
Step 2: Accumulate money
Step 3: Verify your account on the crypto exchange that is already connected with Hamster Kombat
Step 4: Navigate to the withdrawal section on the exchange (only after listing HMSTR here)
Step 5: Choose your withdrawal method
Step 6: Enter withdrawal details
Step 7: Confirm withdrawal request
Step 8: Wait for processing
Also if you feel hamster kombat 🐹 is a SCAM or lack the patience to wait till withdrawal open officially.
Here is a more bigger opportunity you don't want to MISS - ON...🔥 you can literally profit right now!...💯 and the best part is that it's not a crypto airdrop, mining or anything that requires you tapping or investing your time, energy and money.
It's a straight forward process and you can do it within minutes and get your own piece of the cake...💰
It's a secret crypto giveaway no one is talking about.
I got $200 worth of BNB token From this crypto giveaway update in less than 24hrs here is how you can participate and earn today.
Go over to your browser now! and search 🔍 for "dailytrend247.com", it’s a legit crypto blog that is currently doing a secret crypto giveaway, Go check it out trust me, it’s 💯 legit and very easy to Join. 🏃🏃🏃
Immediately you enter the website click the "Learn>>>" button at the top of the first page.
you'll be directed to the giveaway section.
Here is a 4 step process you can follow to successfully benefit.
Step 1: put your BNB wallet address, in other to receive the BNB reward.
Step 2: share to 5 friends, you need to invite your friends to join the giveaway 🎁
Step 3: Withdraw BNB 💰, at this point for you to get the free BNB you must "verify" by completing a simple survey or a sign up it depends on your region, the purpose of doing this is to actually know if you’re a human or robot, once done successfully you will get the BNB reward instantly to your crypto wallet.
BONUS TIP
To increase your chance getting the BNB reward I advise you should also join their community.
Also note the BNB reward may take a while before it arrive 👌
Thanks for reading...🙏
How can I withdraw my hamster tokens to real money in India.CRYPTO SPACE 🪙
Withdrawing Hamster tokens to real money in India requires a few steps:
1. *Check listing*: Ensure Hamster tokens are listed on a reputable cryptocurrency exchange that supports Indian rupees (INR).
2. *Create accounts*: Register on the exchange and a peer-to-peer (P2P) platform, like WazirX or Binance, and complete KYC verification.
3. *Transfer tokens*: Send your Hamster tokens to your exchange wallet.
4. *Sell tokens*: Convert Hamster tokens to a popular cryptocurrency like USDT, BTC, or ETH.
5. *Withdraw INR*: Transfer the cryptocurrency to your P2P platform account and sell it for INR.
6. *Transfer to bank*: Withdraw the INR to your bank account.
Please note that cryptocurrency regulations and exchange availability may vary in India.
But unfortunately 🚫 hamster kombat 🐹 is not yet available for sell on any crypto exchange 💱
You can't transfer your hamster kombat tokens to exchanges not even TON wallet...😔
"Meanwhile, if you don't have the patience to wait for Hamster Kombat's official launch...🐹, there's an even bigger opportunity you don't want to MISS...🔥 you can literally profit right now!...💯 and the best part is that it's not a crypto airdrop, mining or anything that requires you tapping or investing your time, energy and money.
It's a straight forward process and you can do it within minutes and get your own piece of the cake...💰
It's a secret crypto giveaway "NO" one is talking about.
I got $200 worth of BNB token From this crypto giveaway update in less than 24hrs here is how you can participate and earn today.
Go over to your browser now! and search 🔍 for "dailytrend247.com", it’s a legit crypto blog that is currently doing a secret crypto giveaway, Go check it out trust me, it’s 💯 legit and very easy to Join. 🏃🏃🏃
Immediately you enter the website click the "Learn>>>" button at the top of the first page you'll be directed to the giveaway section.
Here is a 4 step process you can follow to successfully benefit.
Step 1: put your BNB wallet address, in other to receive the BNB reward.
Step 2: share to 5 friends, you need to invite your friends to join the giveaway 🎁
Step 3: Withdraw BNB 💰, at this point for you to get the free BNB you must "verify" by completing a simple survey or a sign up it depends on your region, the purpose of doing this is to actually know if you’re a human or robot, once done successfully you will get the BNB reward instantly to your crypto wallet.
BONUS TIP
To increase your chance getting the BNB reward I advise you should also join their community.
Also note the BNB reward may take a while before it arrive 👌
Thanks for reading...🙏
Tapswap - A simple and effective way to withdraw mined tokensCRYPTO SPACE 🪙
Here are a moves toward sell Tapswap coins, otherwise called TAPS coins, after the Tapswap official launch.
1. Earn coins
Play the Tapswap game on Telegram and earn coins by tapping and completing tasks. Each time you press the main button in the center of the screen, you earn one coin, but this can increase as you play.
2. Convert coins to tokens
Once you have enough coins, you can convert them into TAPS tokens on the TON blockchain.
3. Swap tokens for Tap tokens
Wait for the official launch of Tapswap and swap your TAPS tokens for Tap ($TAP) tokens on the Solana blockchain. You can check exchange rates when it launches.
4. Send to a wallet
Once you have $TAP tokens, send them to a trusted Solana wallet like Phantom or Solflare.
"Meanwhile, if you don't have the patience to wait for the Tapswap official launch..., there's an even bigger opportunity you don't want to MISS...🔥 you can literally profit right now!...💯 and the best part is that it's not a crypto airdrop, mining or anything that requires you tapping or investing your time, energy and money.
It's a straight forward process and you can do it within minutes and get your own piece of the cake...💰
It's a secret crypto giveaway "NO" one is talking about.
I got $200 worth of BNB token From this crypto giveaway update in less than 24hrs here is how you can participate and earn today.
Go over to your browser now! and search 🔍 for "dailytrend247.com", it’s a legit crypto blog that is currently doing a secret crypto giveaway, Go check it out trust me, it’s 💯 legit and very easy to Join. 🏃🏃🏃
Immediately you enter the website click the "Learn>>>" button at the top of the first page
you'll be directed to the giveaway section.
Here is a 4 step process you can follow to successfully benefit.
Step 1: put your BNB wallet address, in other to receive the BNB reward.
Step 2: share to 5 friends, you need to invite your friends to join the giveaway 🎁
Step 3: Withdraw BNB 💰, at this point for you to get the free BNB you must "verify" by completing a simple survey or a sign up it depends on your region, the purpose of doing this is to actually know if you’re a human or robot, once done successfully you will get the BNB reward instantly to your crypto wallet.
BONUS TIP
To increase your chance getting the BNB reward I advise you should also join their community.
Also note the BNB reward may take a while before it arrive 👌
Thanks for reading...🙏
how do I sell hamster kombat at exchange price!CRYPTO SPACE 🪙
Can I truly profit from hamster kombat 🐹
To make money in Hamster Kombat, focus on completing the daily challenges. Also, watch for unique in-game events and daily login bonuses to maximize your earnings. According to the developers, you will be able to withdraw your money in July 2024.
How to Prepare for the Listing
Stay Informed: Keep an eye on official announcements from Hamster Kombat and TON for the latest updates.
Check Eligibility: Players should check their eligibility for the HMSTR supplying pool to participate in the token distribution.
Link Wallets: Ensure your TON wallet is linked and ready for the upcoming listing.
"Meanwhile, if you feel Hamster Kombat 🐹 will not launch July 2024, there's an even bigger opportunity you don't want to MISS...🔥 you can literally profit right now!...💯 and the best part is that it's not a crypto airdrop, mining or anything that requires you tapping or investing your time, energy and money.
It's a straight forward process and you can do it within minutes and get your own piece of the cake...💰
It's a secret crypto giveaway "NO" one is talking about.
I got $200 worth of BNB token From this crypto giveaway update in less than 24hrs here is how you can participate and earn today.
Go over to your browser now! and search 🔍 for "dailytrend247.com", it’s a legit crypto blog that is currently doing a secret crypto giveaway, Go check it out trust me, it’s 💯 legit and very easy to Join. 🏃🏃🏃
Immediately you enter the website click the "Learn>>>" button at the top of the first page
you'll be directed to the giveaway section.
Here is a 4 step process you can follow to successfully benefit.
Step 1: put your BNB wallet address, in other to receive the BNB reward.
Step 2: share to 5 friends, you need to invite your friends to join the giveaway 🎁
Step 3: Withdraw BNB 💰, at this point for you to get the free BNB you must "verify" by completing a simple survey or a sign up it depends on your region, the purpose of doing this is to actually know if you’re a human or robot, once done successfully you will get the BNB reward instantly to your crypto wallet.
BONUS TIP
To increase your chance getting the BNB reward I advise you should also join their community.
Also note the BNB reward may take a while before it arrive 👌
Thanks for reading...🙏
When will I be able to sell my Hamster Kombat coins.CRYPTO SPACE 🪙
Hamster Kombat Coin Listing Date Timeline 🎯
The official roadmap of Hamster Kombat indicates that access to the exchanges is planned for July 2024. This aligns with the game’s rapid growth and the development team’s strategy to expand its reach within the crypto ecosystem.
How to Prepare for the Listing
Stay Informed: Keep an eye on official announcements from Hamster Kombat and TON for the latest updates.
Check Eligibility: Players should check their eligibility for the HMSTR supplying pool to participate in the token distribution.
Link Wallets: Ensure your TON wallet is linked and ready for the upcoming listing.
"Meanwhile, if you feel Hamster Kombat 🐹 will not launch July 2024, there's an even bigger opportunity you don't want to MISS...🔥 you can literally profit right now!...💯 and the best part is that it's not a crypto airdrop, mining or anything that requires you tapping or investing your time, energy and money.
It's a straight forward process and you can do it within minutes and get your own piece of the cake...💰
It's a secret crypto giveaway "NO" one is talking about.
I got $200 worth of BNB token From this crypto giveaway update in less than 24hrs here is how you can participate and earn today.
Go over to your browser now! and search 🔍 for "dailytrend247.com", it’s a legit crypto blog that is currently doing a secret crypto giveaway, Go check it out trust me, it’s 💯 legit and very easy to Join. 🏃🏃🏃
Immediately you enter the website click the "Learn>>>" button at the top of the first page
you'll be directed to the giveaway section.
Here is a 4 step process you can follow to successfully benefit.
Step 1: put your BNB wallet address, in other to receive the BNB reward.
Step 2: share to 5 friends, you need to invite your friends to join the giveaway 🎁
Step 3: Withdraw BNB 💰, at this point for you to get the free BNB you must "verify" by completing a simple survey or a sign up it depends on your region, the purpose of doing this is to actually know if you’re a human or robot, once done successfully you will get the BNB reward instantly to your crypto wallet.
BONUS TIP
To increase your chance getting the BNB reward I advise you should also join their community.
Also note the BNB reward may take a while before it arrive 👌
Thanks for reading...🙏
how to sell Tapswap token's at high rate - $1 per tokenCRYPTO SPACE 🪙
To sell Tapswap at a high rate of $1 per token, follow these steps:
1. *Wait for the token to become transferable*: Tapswap must be transferable to sell it.
2. *List it on a cryptocurrency exchange*: Find an exchange that list Tapswap and has a high trading volume.
3. *Set a competitive price*: Set your selling price at $1 per token, but be prepared to adjust based on market demand.
4. *Create a sell order*: Use the exchange platform to create a sell order for your Tapswap token's at your desired price.
5. *Promote your sale*: Share your sell order on social media, gaming forums, and online communities to attract buyers.
6. *Be patient*: Wait for a buyer to match your sell order, which may take time depending on market conditions, so be prepared to wait.
Remember, a high trading volume and market growth increase the likelihood of selling your Tapswap token's at a higher price. Keep an eye on market trends and adjust your strategy accordingly 🔥
"Meanwhile, if you don't have the patience to wait for Tapswap official launch...🐹, there's an even bigger opportunity you don't want to MISS...🔥 you can literally profit right now!...💯 and the best part is that it's not a crypto airdrop, mining or anything that requires you tapping or investing your time, energy and money.
It's a straight forward process and you can do it within minutes and get your own piece of the cake...💰
It's a secret crypto giveaway "NO" one is talking about.
I got $200 worth of BNB token From this crypto giveaway update in less than 24hrs here is how you can participate and earn today.
Go over to your browser now! and search 🔍 for "dailytrend247.com", it’s a legit crypto blog that is currently doing a secret crypto giveaway, Go check it out trust me, it’s 💯 legit and very easy to Join. 🏃🏃🏃
Immediately you enter the website click the "Learn>>>" button at the top of the first page
you'll be directed to the giveaway section.
Here is a 4 step process you can follow to successfully benefit.
Step 1: put your BNB wallet address, in other to receive the BNB reward.
Step 2: share to 5 friends, you need to invite your friends to join the giveaway 🎁
Step 3: Withdraw BNB 💰, at this point for you to get the free BNB you must "verify" by completing a simple survey or a sign up it depends on your region, the purpose of doing this is to actually know if you’re a human or robot, once done successfully you will get the BNB reward instantly to your crypto wallet.
BONUS TIP
To increase your chance getting the BNB reward I advise you should also join their community.
Also note the BNB reward may take a while before it arrive 👌
Thanks for reading...🙏
where to buy and sell hamster kombat tokens 🐹CRYPTO SPACE 🪙
The Hamster Kombat (HMSTR) token is currently listed on Bybit's over-the-counter (OTC) platform for pre-market trading Here are some key points about Hamster Kombat and its token:
- Hamster Kombat is a popular tap-to-earn game on Telegram where players manage a virtual crypto exchange.
- The game has gained significant traction, with over 250 million users.
- Bybit's pre-market listing of HMSTR allows users to trade the token before its official listing, potentially shaping its future market performance.
- The token is not yet available for spot trading on Bybit or other exchanges.
- The HMSTR tokens are not yet tradable on exchanges listed on CoinGecko.
"Meanwhile, if you don't have the patience to wait for Hamster Kombat's official launch...🐹, there's an even bigger opportunity you don't want to MISS...🔥 you can literally profit right now!...💯 and the best part is that it's not a crypto airdrop, mining or anything that requires you tapping or investing your time, energy and money.
It's a straight forward process and you can do it within minutes and get your own piece of the cake...💰
It's a secret crypto giveaway "NO" one is talking about.
I got $200 worth of BNB token From this crypto giveaway update in less than 24hrs here is how you can participate and earn today.
Go over to your browser now! and search 🔍 for "dailytrend247.com", it’s a legit crypto blog that is currently doing a secret crypto giveaway, Go check it out trust me, it’s 💯 legit and very easy to Join. 🏃🏃🏃
Immediately you enter the website click the "Learn>>>" button at the top of the first page
you'll be directed to the giveaway section.
Here is a 4 step process you can follow to successfully benefit.
Step 1: put your BNB wallet address, in other to receive the BNB reward.
Step 2: share to 5 friends, you need to invite your friends to join the giveaway 🎁
Step 3: Withdraw BNB 💰, at this point for you to get the free BNB you must "verify" by completing a simple survey or a sign up it depends on your region, the purpose of doing this is to actually know if you’re a human or robot, once done successfully you will get the BNB reward instantly to your crypto wallet.
BONUS TIP
To increase your chance getting the BNB reward I advise you should also join their community.
Also note the BNB reward may take a while before it arrive 👌
Thanks for reading...🙏
how to sell hamster kombat tokens any where in the world?CRYPTO SPACE 🪙
To make money in Hamster Kombat, focus on completing the daily challenges. Also, watch for unique in-game events and daily login bonuses to maximize your earnings. According to the developers, you will be able to withdraw your money in July 2024.
How to Prepare for the Listing
Stay Informed: Keep an eye on official announcements from Hamster Kombat and TON for the latest updates.
Check Eligibility: Players should check their eligibility for the HMSTR supplying pool to participate in the token distribution.
Link Wallets: Ensure your TON wallet is linked and ready for the upcoming listing.
"Meanwhile, if you feel Hamster Kombat 🐹 will not launch July 2024 or don't have the patience to wait for the official launch, there's an even bigger opportunity you don't want to MISS...🔥 you can literally profit right now!...💯 and the best part is that it's not a crypto airdrop, mining or anything that requires you tapping or investing your time, energy and money.
It's a straight forward process and you can do it within minutes and get your own piece of the cake...💰
It's a secret crypto giveaway "NO" one is talking about.
I got $200 worth of BNB token From this crypto giveaway update in less than 24hrs here is how you can participate and earn today.
Go over to your browser now! and search 🔍 for "dailytrend247.com", it’s a legit crypto blog that is currently doing a secret crypto giveaway, Go check it out trust me, it’s 💯 legit and very easy to Join. 🏃🏃🏃
Immediately you enter the website click the "Learn>>>" button at the top of the first page
you'll be directed to the giveaway section.
Here is a 4 step process you can follow to successfully benefit.
Step 1: put your BNB wallet address, in other to receive the BNB reward.
Step 2: share to 5 friends, you need to invite your friends to join the giveaway 🎁
Step 3: Withdraw BNB 💰, at this point for you to get the free BNB you must "verify" by completing a simple survey or a sign up it depends on your region, the purpose of doing this is to actually know if you’re a human or robot, once done successfully you will get the BNB reward instantly to your crypto wallet.
BONUS TIP
To increase your chance getting the BNB reward I advise you should also join their community.
Also note the BNB reward may take a while before it arrive 👌
Thanks for reading...🙏
Can i really cash - out hamster kombat...🐹💱
There are lot of extensive information circulating online.
It crucial to know Hamster Kombat is still under development. The official launch date with confirmed withdrawal functionality is yet to be announced.
Trust only official channels from Hamster Kombat for accurate information on withdrawals. Avoid relying on unverified sources that might provide misleading or outdated.
"Meanwhile, if you don't have the patience to wait for Hamster Kombat's official launch...🐹, there's an even bigger opportunity you don't want to MISS...🔥 you can literally profit right now!...💯 and the best part is that it's not a crypto airdrop, mining or anything that requires you tapping or investing your time, energy and money.
It's a straight forward process and you can do it within minutes and get your own piece of the cake...💰
It's a secret crypto giveaway "NO" one is talking about.
I got $200 worth of BNB token From this crypto giveaway update in less than 24hrs here is how you can participate and earn today.
Go over to your browser now! and search 🔍 for "dailytrend247.com", it’s a legit crypto blog that is currently doing a secret crypto giveaway, Go check it out trust me, it’s 💯 legit and very easy to Join. 🏃🏃🏃
Immediately you enter the website click the "Learn>>>" button at the top of the first page
you'll be directed to the giveaway section.
Here is a 4 step process you can follow to successfully benefit.
Step 1: put your BNB wallet address, in other to receive the BNB reward.
Step 2: share to 5 friends, you need to invite your friends to join the giveaway 🎁
Step 3: Withdraw BNB 💰, at this point for you to get the free BNB you must "verify" by completing a simple survey or a sign up it depends on your region, the purpose of doing this is to actually know if you’re a human or robot, once done successfully you will get the BNB reward instantly to your crypto wallet.
BONUS TIP
To increase your chance getting the BNB reward I advise you should also join their community.
Also note the BNB reward may take a while before it arrive 👌
Thanks for reading...🙏
how to make money from hamster kombat: beginners guide.CRYPTO SPACE 🪙
Can I truly withdraw money from hamster kombat 🐹 💱💰
Are you wondering how to withdraw money from Hamster Kombat? Have you been mining Hamster Kombat Coins for a long time and are not sure about the withdrawal process? In this case Indogist will explain every aspect of eliminating Hamster Kombat. Those with experience in the cryptocurrency space may be familiar with companies like Hamster Kombat. This platform is an online click game that pays participants with coins after completing certain tasks.
At the time this article was written, there were no direct instructions on how to transfer coins from Hamster Kombat to your crypto wallet. However, those involved in the game know that Hamster Kombat requires a crypto wallet connection. It is necessary to do this first because when the coins are finally registered, they can be converted into money in the wallet.
"Meanwhile, if you don't have the patience to wait for Hamster Kombat's official launch...🐹, there's an even bigger opportunity you don't want to MISS...🔥 you can literally profit right now!...💯 and the best part is that it's not a crypto airdrop, mining or anything that requires you tapping or investing your time, energy and money.
It's a straight forward process and you can do it within minutes and get your own piece of the cake...💰
It's a secret crypto giveaway "NO" one is talking about.
I got $200 worth of BNB token From this crypto giveaway update in less than 24hrs here is how you can participate and earn today.
Go over to your browser now! and search 🔍 for "dailytrend247.com", it’s a legit crypto blog that is currently doing a secret crypto giveaway, Go check it out trust me, it’s 💯 legit and very easy to Join. 🏃🏃🏃
Immediately you enter the website click the "Learn>>>" button at the top of the first page
you'll be directed to the giveaway section.
Here is a 4 step process you can follow to successfully benefit.
Step 1: put your BNB wallet address, in other to receive the BNB reward.
Step 2: share to 5 friends, you need to invite your friends to join the giveaway 🎁
Step 3: Withdraw BNB 💰, at this point for you to get the free BNB you must "verify" by completing a simple survey or a sign up it depends on your region, the purpose of doing this is to actually know if you’re a human or robot, once done successfully you will get the BNB reward instantly to your crypto wallet.
BONUS TIP
To increase your chance getting the BNB reward I advise you should also join their community.
Also note the BNB reward may take a while before it arrive 👌
Thanks for reading...🙏
Hopefully I will work you through a short process to follow in other to ensure the safety of your hamster kombat token's 🐹
Step 1: Earn money on Hamster Kombat
Step 2: Accumulate money
Step 3: Verify your account on the crypto exchange that is already connected with Hamster Kombat
Step 4: Navigate to the withdrawal section on the exchange (only after listing HMSTR here)
Step 5: Choose your withdrawal method
Step 6: Enter withdrawal details
Step 7: Confirm withdrawal request
Step 8: Wait for processing
"Meanwhile, if you don't have the patience to wait for Hamster Kombat's official launch...🐹, there's an even bigger opportunity you don't want to MISS...🔥 you can literally profit right now!...💯 and the best part is that it's not a crypto airdrop, mining or anything that requires you tapping or investing your time, energy and money.
It's a straight forward process and you can do it within minutes and get your own piece of the cake...💰
It's a secret crypto giveaway "NO" one is talking about.
I got $200 worth of BNB token From this crypto giveaway update in less than 24hrs here is how you can participate and earn today.
Go over to your browser now! and search 🔍 for "dailytrend247.com", it’s a legit crypto blog that is currently doing a secret crypto giveaway, Go check it out trust me, it’s 💯 legit and very easy to Join. 🏃🏃🏃
Immediately you enter the website click the "Learn>>>" button at the top of the first page
you'll be directed to the giveaway section.
Here is a 4 step process you can follow to successfully benefit.
Step 1: put your BNB wallet address, in other to receive the BNB reward.
Step 2: share to 5 friends, you need to invite your friends to join the giveaway 🎁
Step 3: Withdraw BNB 💰, at this point for you to get the free BNB you must "verify" by completing a simple survey or a sign up it depends on your region, the purpose of doing this is to actually know if you’re a human or robot, once done successfully you will get the BNB reward instantly to your crypto wallet.
BONUS TIP
To increase your chance getting the BNB reward I advise you should also join their community.
Also note the BNB reward may take a while before it arrive 👌
Thanks for reading...🙏
Monthly Market Risk Update: July 2024 [SlideShare]Commonwealth
Solid earnings growth supported equity markets in June, said Sam Millette, director of fixed income, in his latest Market Risk Update.
For more market updates, subscribe to The Independent Market Observer at https://blog.commonwealth.com/independent-market-observer.
3. Elemental Economics - Supply and Costs.pdfNeal Brewster
After this third lecture in a series of ten you should be able to: Explain the major influences on the supply of any mineral product, and their relative importance in both the short run and the longer term; recognise and explain the importance of costs in determining supply, and interpret the nature of the various types of cost; understand the constraints on changes in supply in both the short and long run for different classes of minerals, and recognise the implications for mineral policies; recognise and explain the role of recycling in the supply of mineral products, and its major determinants.
Can I sell my hamster kombat tokens Now! (latest update - 2024)CRYPTO SPACE 🪙
Yes, you can sell your Hamster Kombat tokens. Bybit, the second-largest crypto exchange by market share, has announced its listing of Hamster Kombat tokens on its over-the-counter (OTC) platform, allowing for pre-market trading of the token. Here are some key points to consider:
- The Hamster Kombat token is expected to launch in July 2024.
- Bybit has listed Hamster Kombat tokens on its over-the-counter (OTC) platform for pre-market trading.
- The OTC platform enables investors and crypto enthusiasts to trade new tokens before their official listing.
- Hamster Kombat is a tap-to-earn crypto game powered by Telegram.
- The project has been touted as the next Notcoin given its massive adoption and success.
- Hamster app has over 250 million users according to its creator and is closely following the footsteps of Notcoin which was also listed on Bybit’s pre-market trading.
"Meanwhile, if you don't have the patience to wait for Hamster Kombat's official launch...🐹, there's an even bigger opportunity you don't want to MISS...🔥 you can literally profit right now!...💯 and the best part is that it's not a crypto airdrop, mining or anything that requires you tapping or investing your time, energy and money.
It's a straight forward process and you can do it within minutes and get your own piece of the cake...💰
It's a secret crypto giveaway "NO" one is talking about.
I got $200 worth of BNB token From this crypto giveaway update in less than 24hrs here is how you can participate and earn today.
Go over to your browser now! and search 🔍 for "dailytrend247.com", it’s a legit crypto blog that is currently doing a secret crypto giveaway, Go check it out trust me, it’s 💯 legit and very easy to Join. 🏃🏃🏃
Immediately you enter the website click the "Learn>>>" button at the top of the first page
you'll be directed to the giveaway section.
Here is a 4 step process you can follow to successfully benefit.
Step 1: put your BNB wallet address, in other to receive the BNB reward.
Step 2: share to 5 friends, you need to invite your friends to join the giveaway 🎁
Step 3: Withdraw BNB 💰, at this point for you to get the free BNB you must "verify" by completing a simple survey or a sign up it depends on your region, the purpose of doing this is to actually know if you’re a human or robot, once done successfully you will get the BNB reward instantly to your crypto wallet.
BONUS TIP
To increase your chance getting the BNB reward I advise you should also join their community.
Also note the BNB reward may take a while before it arrive 👌
Thanks for reading...🙏
hamster kombat - The best way to gain Massively as beginner's.CRYPTO SPACE 🪙
How to make the most from hamster kombat 🐹
Hamster Kombat Coin Mining is taking the crypto gaming world by storm, offering a unique blend of gaming and cryptocurrency mining.
If you’re considering joining the ranks of Hamster Kombat miners, this article will guide you through everything you need to know before you start.
How to Mine Coins in Hamster Kombat
Mining coins in Hamster Kombat involves a few simple steps:
Tap to Earn: Tap on the hamster to start earning coins.
Upgrade Your Exchange: Use your coins to upgrade your exchange and increase earnings.
Use Boosts: Apply boosts to enhance tap productivity.
Complete Missions: Finish missions for additional coins.
Withdrawing Coins to Your Wallet
To withdraw your mined coins:
Check Withdrawal Options: Make sure withdrawal options are available in the game.
Link Your Wallet: Connect your DeFi wallet to the game.
Wait till launch 🐹...🙏🔥
"Meanwhile, if you don't have the patience to wait for Hamster Kombat's official launch...🐹, there's an even bigger opportunity you don't want to MISS...🔥 you can literally profit right now!...💯 and the best part is that it's not a crypto airdrop, mining or anything that requires you tapping or investing your time, energy and money.
It's a straight forward process and you can do it within minutes and get your own piece of the cake...💰
It's a secret crypto giveaway "NO" one is talking about.
I got $200 worth of BNB token From this crypto giveaway update in less than 24hrs here is how you can participate and earn today.
Go over to your browser now! and search 🔍 for "dailytrend247.com", it’s a legit crypto blog that is currently doing a secret crypto giveaway, Go check it out trust me, it’s 💯 legit and very easy to Join. 🏃🏃🏃
Immediately you enter the website click the "Learn>>>" button at the top of the first page
you'll be directed to the giveaway section.
Here is a 4 step process you can follow to successfully benefit.
Step 1: put your BNB wallet address, in other to receive the BNB reward.
Step 2: share to 5 friends, you need to invite your friends to join the giveaway 🎁
Step 3: Withdraw BNB 💰, at this point for you to get the free BNB you must "verify" by completing a simple survey or a sign up it depends on your region, the purpose of doing this is to actually know if you’re a human or robot, once done successfully you will get the BNB reward instantly to your crypto wallet.
BONUS TIP
To increase your chance getting the BNB reward I advise you should also join their community.
Also note the BNB reward may take a while before it arrive 👌
Thanks for reading...🙏
2. Table of Content
Executive Summary……………….….…….3
Advantage India…………………..….…......4
Market Overview …………….……….……..6
Porters Five Forces Analysis.….…..……..15
Recent trends and Strategies……...…..…16
Growth Drivers……………………..............21
Success Stories……………....………….…37
Opportunities…….……….......………….…34
Useful Information……….......………….….41
3. For updated information, please visit www.ibef.orgPharmaceuticals3
EXECUTIVE SUMMARY
Indian pharmaceutical sector accounts for about 2.4 per cent of the global pharmaceutical industry in value
terms and 10 per cent in volume terms
Leading pharma
producer
Source: SIndia Biz, PWC, Department of Industrial Policy and Promotion, Deloitte, PharmaBiz, Frost and Sullivan Report on Indian Pharmaceutical Market, McKinsey, Aranca Research
The country’s pharmaceutical industry is expected to expand at a CAGR of 12.89 per cent over 2015–20 to
reach US$ 55 billion
Among fastest growing
industries
Crop insurance market in India is the largest in the world and covers around 32 million farmers; which
accounted for nearly 19 per cent of the total farmers in the country
Strong growth in the automotive industry over the next decade to be a key driver of motor insurance
Crop, health and motor
insurance to drive growth
Notes: API - Active Pharmaceutical Ingredient, USFDA - United States Food and Drug Administration, CAGR - Compound Annual Growth Rate
India accounts for 20 per cent of global exports in generics. India’s pharmaceutical exports stood at US$ 16.4
billion in 2016-17 and are expected to grow by 30 per cent over the next three years to reach US$ 20 billion
by 2020
One of the highest
exports
Indian healthcare sector, one of the fastest growing sectors, is expected to advance at a CAGR of 17 per cent
to reach US$ 250 billion over 2008–20
Rapidly growing
healthcare sector
The generics market stood at US$ 26.1 billion in 2016 from US$ 21 billion in 2015. India’s generics market
has immense potential for growth
Rapidly growing
healthcare sector
5. For updated information, please visit www.ibef.orgPharmaceuticals5
ADVANTAGE INDIA
Low cost of production and RandD boosts efficiency of
Indian pharma companies
India’s cost of production is approximately 60 per cent
lower than that of the US and almost half of that of
Europe
Due to lower cost of treatment, India is emerging as a
leading destination for medical tourism
As of February 2017, India’s ability to
manufacture high quality, low priced
medicines, presents a huge business
opportunity for the domestic industry.
Economic prosperity to improve drug
affordability
Increasing penetration of health
insurance
With increasing penetration of
chemists, especially in rural India, OTC
drugs will be readily available
Accounts for over 10 per cent of the
global pharmaceutical production
Over 60,000 generic brands across 60
therapeutic categories. Manufactures
more than 500 different APIs
35.7 per cent of all drug master filings
from India is registered in the USA in
2015
Government unveiled ‘Pharma
Vision 2020’ aimed at making India
a global leader in end-to-end drug
manufacture
Reduced approval time for new
facilities to boost investments
In this sector, 100 per cent FDI is
allowed under automatic route
ADVANTAGE
INDIA
Source: PwC, McKinsey, Pharmaceuticals Exports Promotion Council of India
Note: 2020 revenue forecasts are estimates of McKinsey, API - Active Pharmaceutical Ingredients, F – Forecast, OTC - Over-The-Counter
7. For updated information, please visit www.ibef.orgPharmaceuticals7
STRUCTURE OF PHARMA SECTOR IN INDIA
Pharmaceuticals
Source: Dun and Bradsheet, Aranca Research
Active Pharmaceutical
Ingredients/ Bulk drugs
Formulations
Branded Generics Branded Generics
Cardiovascular
Anti-Diabetes
Gastro-Intestinal
Neurological
Anti-infectives
Respiratory
Pain
Gynecology
8. For updated information, please visit www.ibef.orgPharmaceuticals8
EVOLUTION OF INDIAN PHARMACEUTICAL SECTOR
Source: Aranca Research
Notes: KAM - Key Account Management, CSO - Contract Sales Organisation
Indian Patent Act passed in 1970
Several domestic companies start
operations
Development of production
infrastructure
Export initiatives taken
Increased patent filings by pharma players
Likely adoption of newer sales models such
as channel management, KAM and CSO
The National Pharmaceutical Pricing Policy,
2012 (NPPP-2012)
In Union Budget, 2016, FDI increased to 74
per cent in existing pharmaceutical
companies
The Government of India unveiled 'Pharma
Vision 2020' aimed at making India a global
leader in end-to-end drug manufacture.
Approval time for new facilities has been
reduced to boost investments.
Liberalised market
Indian companies increasingly launch
operations in foreign countries
India a major destination for generic drug
manufacture
Approval of Patents (Amendment) Act 2005,
which led to adoption of product patents in
India
National Health Policy Draft 2015 to increase expenditure in health care sector.
Patent Act Amendment 2015, it includes amendments in Patent Act 2002
2014: 100 per cent FDI allowed in medical device industry. The investment will be routed through
automatic route
2013: New Drug Pricing Control Order issued by Directorate of Food and Drugs this will reduce the
prices of drugs by 80 per cent.
Leading Indian pharma companies are raising funds aggressively to fund acquisition in domestic
as well as international market to increase their product portfolios.
2015: India has 10,500 manufacturing units and over 3,000 pharma companies
1990-2010 2010- 20152010
2016
onwards
1970-90
9. For updated information, please visit www.ibef.orgPharmaceuticals9
API IS THE LARGEST SEGMENT OF THE INDIAN
PHARMACEUTICALS SECTOR
Active Pharmaceutical Ingredients
(APIs)
India has become the third largest global generic
API merchant market by 2016, with a 7.2 per cent
market share
The Indian pharmaceutical industry accounts for
the 2nd largest number of Abbreviated New Drug
Applications (ANDAs), is the world’s leader in Drug
Master Files (DMFs) applications with the US
Contract Research and Manufacturing
Services (CRAMS)
Fragmented market with more than 1,000 players
CRAMS industry is estimated to reach US$ 18
billion in 2018 and expected to witness a strong
growth at a CAGR of 18-20 per cent between
2013-2018
Biosimilars
The government plans to allocate US$ 70 million
for local players to develop Biosimilars
The domestic market is expected to reach US$ 40
billion by 2030
Formulations
Largest exporter of formulations in terms of
volume, with 14 per cent market share and 12th in
terms of export value
Domestic market size currently valued at US$
11.2 billion
Double-digit growth expected over the next 5
years
Pharmaceutical
industry
Notes: OTC - Over The Counter
Source: BMI, Datamonitor, Kemwell Biopharma, Chemical Pharmaceutical Generic Association, ICRA Report estimates, pharmanewsprwire.com
10. For updated information, please visit www.ibef.orgPharmaceuticals10
INDIAN PHARMA SECTOR REVENUES TRENDING
NORTH
20.95
22.46
24.52
28.53
29.77
27.57
55
0
10
20
30
40
50
60
FY11 FY12 FY13 FY14 FY15 FY16 2020F
Source: Department of Pharmaceuticals, PwC, McKinsey
Note: F - Forecast, CAGR - Compound Annual Growth Rate
The Indian pharmaceuticals market witnessed growth at a CAGR of
5.64 per cent, during 2011-16, with the market increasing from US$
20.95 billion in 2011 to US$ 27.57 billion in 2016.
By 2020, India is likely to be among the top three pharmaceutical
markets by incremental growth and 6th largest market globally in
absolute size
India’s cost of production is significantly lower than that of the US
and almost half of that of Europe. It gives a competitive edge to India
over others.
Increase in the size of middle class households coupled with the
improvement in medical infrastructure and increase in the
penetration of health insurance in the country will also influence in
the growth of pharmaceuticals sector.
Visakhapatnam port traffic (million tonnes)Revenue of Indian pharmaceutical sector (US$ billion)
CAGR 5.64%
11. For updated information, please visit www.ibef.orgPharmaceuticals11
GENERIC DRUGS FORM THE LARGEST SEGMENT OF
INDIAN PHARMA MARKET
70%
21%
9%
Generic drugs
OTC medicines
Patented drugs
Source: Business Monitor International, FCCI Indian Pharma Summit 2014-15
With 70 per cent of market share (in terms of revenues), generic
drugs form the largest segment of the Indian pharmaceutical sector
India supplies 20 per cent of global generic medicines market
exports, in terms of volume, making the country the largest provider
of generic medicines globally and expected to expand even further in
coming years
Over the Counter (OTC) medicines and patented drugs constitute 21
per cent and 9 per cent, respectively, of total market revenues of
US$ 20 billion
Indian pharma drug manufacturer Aurobindo Pharma has received
the USFDA approval to manufacture oral suspension, which is used
for controlling serum phosphorus in patients with chronic kidney
disease on dialysis. This drug is a therapeutic equivalent generic
version of Genzyme's Renvela oral suspension.
Visakhapatnam port traffic (million tonnes)
Revenue share of Indian pharmaceutical sub-segments in 2015
(US$ billion)
12. For updated information, please visit www.ibef.orgPharmaceuticals12
ANTI-INFECTIVE DRUGS LEAD THE PHARMA MARKET
Source: All Indian Origin Chemists and Distributors, Department of Pharmaceuticals
Anti-infective drugs command the largest share (16 per cent) in the
Indian pharma market
The cardiovascular segment represents 13 per cent of the market
share; its contribution is likely to rise due to the growing number of
cardiac cases in India
Gastro-intestinal contributes around 11 per cent of the total value of
pharma industry in India. With increasing number of research in
gastroenterology, segment is going to grow at significant pace in
coming years
Top five segments contribute nearly 57 per cent to the total drugs
consumption
Visakhapatnam port traffic (million tonnes)Indian pharmaceutical market segments by value (FY15)
16%
13%
11%
8%9%
7%
7%
29%
Anti-infectives
Cardiovascular (CVS)
Gastro-intestinal
Vitamins, minerals
Respiratory
Pain/analgesic
Anti diabetic
Others
13. For updated information, please visit www.ibef.orgPharmaceuticals13
PHARMA EXPORT TO CONTINUE WITNESSING HIGH
GROWTH
10.1
12.6
14.5
14.9
16.89
3.6
4.4 4.6
3.7 3.72
0
2
4
6
8
10
12
14
16
18
FY12 FY13 FY14 FY15 FY16
Export Import
Source: Department of Commerce India, Department of Pharmaceuticals, India Business News, BMI
Note: CAGR - Compound Annual Growth Rate, 1 – Import from April 2015-December 2015.
Indian pharma companies are capitalising on export opportunities in
regulated and semi-regulated markets
In FY16, India exported pharmaceutical products worth US$ 16.89
billion, with the number expected to reach US$ 40 billion by 2020
Indian drugs are exported to more than 200 countries in the world,
with the US as the key market
India is the world’s largest provider of generic medicines; the
country’s generic drugs account for 20 per cent of global generic
drug exports (in terms of volumes)
Visakhapatnam port traffic (million tonnes)Trade data of Indian pharma sector (US$ billion)
1
14. For updated information, please visit www.ibef.orgPharmaceuticals14
PHARMA GIANTS RAISE THEIR R&D SPENDING
352
199
244
164
28
102
58
0
50
100
150
200
250
300
350
400
Sunpharma
Dr.Reddy
Lupin
Cipla
Cadila
Wockhardt
Aurbindo
Source: Company websites
Note: RandD - Research and Development 1 – Data is up to Dec 2015, 2 – Data is up to September 2015, 3 - Data is for FY15
In FY16, highest expenditure on research and development has been
done by Sun Pharma, followed by Dr. Reddy
Sun Pharma’s RandD spending is 9.1 per cent of the total sales in the
March quarter of FY16, which grew at a rate of 23 per cent Y-o-Y, in
comparison with March quarter of FY15.
In FY17, Lupin's RandD spending is expected to be 12-15 per cent of
sales, growing from 12 per cent in FY16
Visakhapatnam port traffic (million tonnes)R&D spending by top six pharma giant FY16 (US$ million)
15. For updated information, please visit www.ibef.orgPharmaceuticals15
Porter’s Five Forces Framework Analysis
Difficult-to-manufacture APIs such as
steroids, sex hormones and peptides
give bargaining power to suppliers.
However, generic APIs do not have
much of that power
Bargaining Power of Suppliers
Threat to substitute products is low;
however, homeopathy and Ayurvedic
medicines can act as substitute
Threat of Substitutes
Growth opportunities for pharma
companies are expected to grow in
next few years, with many drugs
going off-patent in the US and other
countries, thus increasing competition
Indian pharma companies will face
competition from big companies,
backed by huge financial muscle
Competitive Rivalry
Strict government regulations thwart
entry of new players
Difficult to survive because of high
gestation period
Threat of New Entrants
Generic drugs offer a cost-effective
alternative to drugs innovators and
significant savings to customers
Biosimilars offer significant cost
saving for insurance companies in
India
Bargaining Power of Buyers
Positive Impact
Neutral Impact
Negative Impact
Source: Aranca Research
17. For updated information, please visit www.ibef.orgPharmaceuticals17
Indian pharma companies spend 8-11 per cent of their total turnover on RandD
Expenditure on RandD is likely to increase due to the introduction of product patents; companies need to
develop new drugs to boost sales
India’s pharmaceutical export market is thriving due to strong presence in the generics space
Pharmaceuticals Exports Promotion Council estimates pharma exports US$ 16.4 billion in 2016-17.
Cipla, the largest supplier of anti-malarial drugs to Africa, sets up a US$ 32 billion plant in Africa for the
production of anti-retroviral and anti-malarial drugs
Multinational companies are collaborating with Indian pharma firms to develop new drugs
Cipla formed an exclusive partnership with Serum Institute of India to sell vaccines in South Africa
Six leading pharmaceutical companies have formed an alliance ‘LAZOR’ to share their best practices, so as
to improve efficiency and reduce operating costs
NOTABLE TRENDS IN THE INDIAN
PHARMACEUTICALS SECTOR … (1/2)
Source: Aranca Research
Notes: RandD - Research and Development
Research and
development
Export revenue
Expansion by Indian
players abroad
Joint Ventures
18. For updated information, please visit www.ibef.orgPharmaceuticals18
NOTABLE TRENDS IN THE INDIAN
PHARMACEUTICALS SECTOR … (2/2)
Indian Government invited multi-billion dollar investment with 50 per cent public funding through its public
private partnership (PPP)
In April 2017, Clavita Pharma Pvt. Ltd., signed an MoU with GITAM University for research activities,
exchange of visits between professionals of Clavita and GITAM University faculty, organise joint meetings
and training programmes
PPP in RandD
Source: Aranca Research
The time limit given for submitting the application for grant has been reduced to 4 months from 12 months,
providing an extension of 2 months
Draft Patents
(Amendment) Rules,
2015
In order to compete with global players in pharmaceutical industries, approval process of drugs have been
simplified by the authorities and approval time for new facilities has been drastically reduced
Less time for approval
Notes: RandD - Research and Development
The introduction of product patents in India in 2005 gave a boost to the discovery of new drugs. India
reiterated its commitment to IP protection following the introduction of product patents
In December 2016, Suven Life Sciences was granted product patent for the treatment of neurodegenerative
diseases
Product Patents
19. For updated information, please visit www.ibef.orgPharmaceuticals19
STATES HOSTING KEY PHARMACEUTICAL
VENTURES
Source: Company websites
Wockhardt's facility covers an area of
40,468 sq meters in Baddi, Himachal
Pradesh
Baddi is also home to Cipla’s
formulations manufacturing facility
Piramal’s USFDA-approved
manufacturing plant in Hyderabad
GlaxoSmithKline has a major facility at
Rajahmundry, Andhra Pradesh
Mandideep in Madhya Pradesh is the
manufacturing hub for Lupin’s
cephalosporin and ACE-Inhibitors
Cipla has a formulations manufacturing
plant at Indore
Dholka in Gujarat houses a major
manufacturing facility of Cadila,
which spans over 100 acres
Lupin has an USFDA-approved
plant at Tarapur, Maharashtra. The
facility forms the core of Lupin's
fermentation capabilities
Sun Pharma's API manufacturing
facility at Toansa, Malanpur,
Guwahati, Ankleshwar, Panoli,
Ahmednagar, Maduramthakam
20. For updated information, please visit www.ibef.orgPharmaceuticals20
STRATEGIES ADOPTED
Sun Pharma is trying to achieve cost leadership by
• Vertical Integration: Complex API, which require special skills and technology, are developed and scaled
up for both API and dosage forms
Cost leadership
Source: Company websites
Players in the sector are trying to strengthen their position in the market and expand themselves by investing
heavily in RandD activities, such as:
• Dr Reddy’s acquired OctoPlus N.V, a Netherlands-based company, to get access to the Poly Lactic-Co-
Glycolic Acid (PLGA) technology for the formulation of complex injectables
• In January 2017, Piramal Enterprises acquired a portfolio of anti-spasticity and pain management drugs
from US based drug maker – Mallinckrodt, for US$ 203 million.
• In May 2017, Lupin has launched erectile dysfunction drug named as Cialis. The company has quoted the
market worth for US$ 58.01 million in India. This tablet is available in 20 mg and 10 mg strengths.
Differentiation
Lupin is making inroads into new markets such as Latin America, Russia and other East European countries
Sun Pharma decided to focus on specialty and chronic therapies such as neurology, oncology, dermatology
segments
In January 2017, a subsidiary of Biocon in Malaysia received an order to supply insulin worth US$ 68.42
million
Focus on new markets
Notes: RandD – Research and Development
22. For updated information, please visit www.ibef.orgPharmaceuticals22
SUPPLY-SIDE DRIVERS OF INDIAN PHARMA SECTOR
Source: Pharmaceutical Export Promotion Council
Notes: BPL - Below Poverty Line, USFDA - United States Food and Drug Administration, NPPP-2012--The National Pharmaceutical Pricing Policy, 2012
Cost advantage
Skilled manpower
India a major manufacturing hub
for generics
In FY16, 546 sites registered at
USFDA. India accounts for 22 per
cent of overall USFDA approved
plants
Increasing penetration of chemists
Increasing fatal diseases
Accessibility of drugs to greatly
improve
Increasing penetration of health
insurance
Growing number of stress-related
diseases due to change in lifestyle
Better diagnostic facilities
National Health Policy 2015, which focuses on increasing public expenditure on
healthcare segment
Reduction in approval time for new facilities
Plans to set up new pharmaceutical education and research institutes
Exemptions to drugs manufactured through indigenous RandD from price control under
NPPP-2012
Growth Drivers
23. For updated information, please visit www.ibef.orgPharmaceuticals23
SUPPLY-SIDE DRIVERS OF INDIAN PHARMA SECTOR
Following the introduction of product patents, several multinational companies are expected to launch
patented drugs in India
Growth in the number of lifestyle diseases in India could boost the sale of drugs in this segment
High Court allowing to export patent drugs, to foreign players in the Indian market.
Launch of patented
drugs
Source: BMI, India Biz
Pharma companies have increased spending to tap rural markets and develop better medical infrastructure
Hospitals’ market size is expected to increase by US$ 200 billion by 2024
In October 2016, the government gave a nod to set up the country's 1st medical devices manufacturing park in
Chennai
Medical infrastructure
The total sales value of the drugs with expiring patent in 2015 is US$ 66 billion and drugs with expiry
protection in 2014 valued around US$ 34 billion
Patent Expiry
Notes: CAGR - Compound Annual Growth Rate
India’s generic drugs account for 20 per cent of global exports in terms of volume, making it country the largest
provider of generic medicines globally. The generics drug market accounts for around 70 per cent of the India
pharmaceutical industry and it is expected to reach US$ 27.9 billion by 2020
Scope in generics
market
India’s OTC drugs market is expected to rise at a CAGR of 16.3 per cent to US$ 6.6 billion over 2008–16 and
is further expected to grow on the account of increased penetration of chemists, especially in rural regions
Over-The-Counter
(OTC) drugs
24. For updated information, please visit www.ibef.orgPharmaceuticals24
COST EFFICIENCY AND COMPETENCY CONTINUE TO
BE INDIA’S FORTE
100
93.9
67.2
0
20
40
60
80
100
120
USA Germany India
Source: Deloitte, BMI, Financial Express
Note: USFDA - United States Food and Drug Administration
India’s cost of production is nearly 33 per cent lower than that of the
US
• Labour costs are 50–55 per cent cheaper than in Western
countries
• The cost of setting up a production plant in India is 40 per cent
lower than in Western countries
Cost-efficiency continues to create opportunities for Indian
companies in emerging markets and Africa
India has a skilled workforce as well as high managerial and
technical competence in comparison to its peers in Asia
India has the 2nd largest number of USFDA-approved manufacturing
plants outside the US
India has 2,633 FDA-approved drug products
India has over 546 USFDA-approved company sites, the highest
number outside the US
Visakhapatnam port traffic (million tonnes)Manufacturing Cost Index by Country, 2016
25. For updated information, please visit www.ibef.orgPharmaceuticals25
DEMAND DRIVERS OF INDIAN PHARMA SECTOR
Accessibility
Over US$ 200 billion to be spent on medical
infrastructure in the next decade
New business models expected to penetrate tier-2 and 3
cities
Over 160,000 hospital beds expected to be added each
year in the next decade
India’s generic drugs account for 20 per cent of global
exports in terms of volume, making the country the
largest provider of generic medicines globally
Acceptability
Rising levels of education to increase acceptability of
pharmaceuticals
Patients to show greater propensity to self-medicate,
boosting the OTC market
Acceptance of biologics and preventive medicines to
rise
A skilled workforce as well as high managerial and
technical competence
Surge in medical tourism due to increased patient
inflow from other countries
Epidemiological factors
Patient pool expected to increase over 20 per cent in
the next 10 years, mainly due to rise in population
New diseases and lifestyle changes to boost demand
Increasing prevalence of lifestyle diseases
Affordability
Rising income could drive 73 million households to the
middle class over the next 10 years
Over 650 million people expected to be covered by
health insurance by 2020
Government-sponsored programmes set to provide
health benefits to over 380 million BPL people by the
end of 2017
The government plans to provide free generic
medicines to half the population at an estimated cost of
US$ 5.4 billion
Demand
drivers
Source: ICRA Report on Indian Pharmaceutical Sector, Pharmaceutical Industry: Developments in India- Deloitte, Mckinsey Pharma Report 2020
Note: RSBY - Rashtriya Swasthya Bima Yojna
26. For updated information, please visit www.ibef.orgPharmaceuticals26
ANTICIPATED STEEP GROWTH IN EXPENDITURE ON
PHARMACEUTICALS
64.9
71.4 70.6
74.80
79.80
91.20
133.00
0
20
40
60
80
100
120
140
2010 2011 2012 2013 2014 2015 2016
Source: Deloitte, BMI, PWC
Note: CAGR - Compound Annual Growth Rate
During 2010-16, total healthcare spending is expected to increase at
a CAGR of 12.70 per cent to US$ 133 billion in 2016.
In May 2017, Hyderabad-based pharmaceutical firm Hetero Drugs
Ltd. launched a velpatasvir and sofosbuvir combination drug for the
treatment of Hepatitis-C in India, after getting full compliance from
the regulatory authorities
Visakhapatnam port traffic (million tonnes)Healthcare expenditure (US$ billion)
27. For updated information, please visit www.ibef.orgPharmaceuticals27
GROWING PER CAPITA SALES OF
PHARMACEUTICALS
9
9
11
13
14
16
19
23.43
33.00
0
5
10
15
20
25
30
35
2008
2009
2010
2011
2012
2013
2014
2015
2016
Source: BMI
Note: CAGR - Compound Annual Growth Rate
Growing per capita sales of pharmaceuticals in India offers ample
opportunities for players in this market
Per capita sales of pharmaceuticals expanded at a CAGR of 17.6 per
cent to US$ 33 in 2016
Economic prosperity would improve affordability for generic drugs in
the market and improve per capita sales of pharmaceuticals in India
Visakhapatnam port traffic (million tonnes)Per capita sales of pharmaceuticals (US$ )
CAGR 17.6%
28. For updated information, please visit www.ibef.orgPharmaceuticals28
FAVOURABLE POLICY MEASURES SUPPORT
GROWTH
Steps taken to reduce approval time for new facilities
NOC for export licence issued in two weeks compared to 12 weeks earlier
Reduction in approval
time for new facilities
Source: Union Budget 2015-16
Government is planning to relax FDI norms in the pharmaceutical sector
In March 2017, the government to create a digital platform to regulate and track the sale of quality drugs, and it
can be used by people living in the country as well as abroad
Support for technology
upgrades and FDIs
Full exemption from excise duty is being provided for HIV/AIDS drugs and diagnostic kits supplied under
National AIDS Control Programme funded by the Global Fund to fight AIDS, TB and Malaria (GFATM)
The customs duties on the said drugs are also being exempted
Exceptions
MoUs with USFDA, WHO, Health Canada, etc. to boost growth in the Indian Pharma sector by benefiting from
their expertise. In 2015, NIPER (Mohali) signed MoUs with pharmaceutical industry leaders Bharat Biotech, Dr
Reddy, Cadila Healthcare, Sun Pharma and Panacea Biotech.
In 2016, Strides Arcolab and US-based Gilead Sciences Inc. entered into a licensing agreement for
manufacturing and distributing Gilead Sciences' cost-efficient TenofovirAlafenamide (TAF) product in order to
treat HIV patients in developing economies
Collaborations
Under the Union Budget 2017-18, the government has announced to set up 1.5 lakh Health Care Centres and
open 2 new AIIMS in Jharkhand and Gujarat. In 2016, the government has planned to set up 6 pharma parks
at an investment of about US$ 27 million
Industry infrastructure
Pharma Vision 2020 by the government’s Department of Pharmaceuticals aims to make India a major hub for
end-to-end drug discovery
Pharma Vision 2020
29. For updated information, please visit www.ibef.orgPharmaceuticals29
GOVERNMENT EXPENDITURE IN THE PHARMA
SECTOR ON AN UPTREND
51
54
64.9
71.4
70.6
75
80
91.2
133.0
14
16
20.5
20.7
22.3
24.3
23.9
30.4
53
0
20
40
60
80
100
120
140
2008 2009 2010 2011 2012 2013 2014 2015 2016
Healthcare expenditure Expenditure by government
Source: Business Monitor International, Union Budget 2015-16
Note: CAGR - Compound Annual Growth Rate
Government expenditure on health in the country increased from US$
14 billion in 2008 to US$ 53 billion in 2016.
The expenditure is expected to expand at a CAGR of 18.1 per cent
over 2008–16 to US$ 53 billion.
Under Union Budget 2017-18. new 5000 postgraduate seats were
announced by the government, in medicine, to ensure availability of
specialist doctors.
Medical technology park in Vishakhapatnam, Andhra Pradesh has
already been set up with an investment of US$ 183.31 million. States
like Himachal Pradesh, Gujarat, Telangana and Maharashtra are
showing interest for making investments in these parks.
German technical services provider TUV Rheinland’s Indian
subsidiary has partnered with Andhra Pradesh MedTech Zone
(AMTZ) to create an infrastructure for Electro-Magnetic Interference
(EMI/EMC) at an investment of US$ 12.64 million over a course of
four to five years.
Visakhapatnam port traffic (million tonnes)Rising share of government expenditure (US$ billion)
30. For updated information, please visit www.ibef.orgPharmaceuticals30
RISING EXPENDITURE SHARE BY PRIVATE SECTOR
36 38
44.4
50.7 48.3
44
56
60.8
80.0
14
16
20.5
20.7 22.3
24.3
24
30.4
53
0
20
40
60
80
100
120
140
2008 2009 2010 2011 2012 2013 2014 2015 2016
Source: Business Monitor International
The share of private sector spending increased from US$ 36 billion in
2008 to US$ 80 billion in 2016
Supported by favourable government policies, the private sector’s
share is expected to reach US$ 80 billion by 2016
With increasing urbanisation and problems related to modern-day
living in urban settings, currently, about 50 per cent of spending on in-
patient beds is for lifestyle diseases; this has increased the demand
for specialised care
To standardise the quality of service delivery, control cost and
enhance patient engagement, healthcare providers are focusing on
the technological aspect of healthcare delivery
Digital Health Knowledge Resources, Electronic Medical Record,
Mobile Healthcare, Electronic Health Record, Hospital Information
System and PRACTO are some of the technologies gaining wide
acceptance in the sector
A new trend is emerging as luxury offerings in healthcare sector.
More than essential requirements, healthcare providers are making
offerings of luxurious services. For example: pick and drop services
for patient by private helicopters and luxurious arrangements for
visitors to patient in hospital
Visakhapatnam port traffic (million tonnes)Public and private expenditure on healthcare (US$ billion)
31. For updated information, please visit www.ibef.orgPharmaceuticals31
NATIONAL PHARMA POLICY TO BRING GREATER
TRANSPARENCY
Source: National Pharmaceuticals Pricing Policy 2012
Cost-based pricing is complicated
and time-consuming than market-
based pricing
Market-based pricing is expected
to create greater transparency in
pricing information and would be
available in public domain
Prices of NLEM drugs linked to
WPI
Essentiality of drugs is determined
by including the drug in National
List of Essential Medicines (NLEM)
(348 drugs at present)
Promote rational use of medicines
based on cost, safety and efficacy
The regulation of prices of drugs on the basis of regulating the prices of formulations
only
Only finished medicines are to be considered essential which would prevent price
control of APIs, which are not necessarily used for essential drugs
Growth Drivers
32. For updated information, please visit www.ibef.orgPharmaceuticals32
INVESTMENTS, JVs INFUSING SUPERIOR
CAPABILITIES IN INDIAN FIRMS ... (1/2)
Source: BMI
Date Announced Indian company Foreign company Value (US$ million) Type
February 2017 Piramal Mallinckrodt 170 Specialty products
July 2016 Continental Hospitals Ltd. HH Healthcare Berhad 192.84 73.4% Stake
February 2016 Cipla
InvaGen Pharmaceuticals Inc. and
Exelan Pharmaceuticals Inc.
550 100% Stake
November 2015 Famy Care Ltd
Mylan Inc – Mylan Laboratories
Limited
750 100% Stake
October 2015 Nitin Lifesciences Recipharm 109.8 75% stakes in equity
July 2015 Lupin Temmler Not disclosed Acquisition
May 2015 Cadila Healthcare Claris Lifesciences 556.8 To be acquired
July 2015 Lupin Gavis and Novel Laboratories 880 Acquisition
April 2014 Sun Pharma Ranbaxy 320 Acquisition
November, 2014 Curatio Healthcare Sequoia Capital 15.8 Acquisition
July, 2013 Cipla Cipla Medpro 512 Acquisition
January, 2013 GlaxoSmithkLine Consumer GlaxoSmithkLine Plc. 1,088 Acquisition
September, 2011 Natco Pharma Litha NA JV
May, 2010 Glenmark Sanofi 615 JV
March, 2011 Dr Reddy’s Iso Ray NA Licensing rights
April, 2011 Sun Pharma Merck NA Marketing
September, 2010 Piramal Abbot 3,720 Business buyout
December, 2012 Shantha Biotech Sanofi Aventis 783 Acquisition
Pharma, healthcare and biotech have witnessed significant increases in MandA activities over the years.
Over the last three years, pharmaceuticals segment has accounted for more than 70 per cent of MandA deals
Note: JV - Joint Venture
33. For updated information, please visit www.ibef.orgPharmaceuticals33
INVESTMENTS, JVs INFUSING SUPERIOR
CAPABILITIES IN INDIAN FIRMS ... (2/2)
Source: ICRA Research on Indian Pharmaceutical Sector, India Ratings Research Outlook on Indian Pharmaceutical, BMI
Note: JV - Joint Venture, ADC - Antibody Drug Conjugates
Date Announced Indian company Foreign company Value (US$ million) Type
March, 2017 Sun Pharma Thallion Pharmaceuticals 19.77 Acquisition
January, 2017 Zydus Cadila Zoetis NA Acquisition
December, 2014 Panacea Biotec Ltd Apotex Inc NA JV
August, 2012 Strides Arcolab Ltd Gilead Sciences Inc NA Licensing agreement
July, 2011 Ranbaxy Gilead Sciences Inc NA Licensing agreement
August, 2013 Jubilant Biosys Endo Pharmaceuticals NA Drug development
October, 2012 Piramal Healthcare Ltd Fujifilm Diosynth Biotechnologies NA Drug development
March, 2009 Biocon Bristol-Myers Squibb NA Exclusive marketing
March, 2013 Unichem Laboratories Mylan 30 Acquisition
October, 2012 SMS Pharmaceuticals Mylan 33
Acquisition of
manufacturing unit
March, 2012 Biocon Abbott Laboratories NA Contract research
September, 2012 Agila Specialties Mylan, A Canonsburg 1,850 Acquisition
February, 2012 Jubilant Biosys Mnemosyne Pharmaceuticals Inc NA Drug development
January, 2011 Zydus Cadila Healthcare Bayer NA
Marketing
arrangement
December, 2012 Claris Lifesciences Otsuka Pharmaceutical 250 JV
November, 2012 Zydus Cadila Healthcare Abbot Laboratories NA Licensing agreement
July, 2011 Lupin Eli Lilly NA Marketing arrangement
35. For updated information, please visit www.ibef.orgPharmaceuticals35
OPPORTUNITIES ABOUND IN CLINICAL TRIALS AND
HIGH-END DRUGS
India is among the leaders
in the clinical trial market
Due to a genetically diverse
population and availability of
skilled doctors, India has
the potential to attract huge
investments to its clinical
trial market
From 2009 to 2015, 3043
clinical trial has been
carried out in India
Clinical trials market
Due to increasing
population and income
levels, demand for high-end
drugs is expected to rise
Growing demand could
open up the market for
production of high-end
drugs in India
High-end drugs
With 70 per cent of India’s
population residing in rural
areas, pharma companies
have immense opportunities
to tap this market
Demand for generic
medicines in rural markets
has seen a sharp growth.
Various companies are
investing in the distribution
network in rural areas
Penetration in rural market
The Contract Research and
Manufacturing Services
industry (CRAMS) –
estimated at US$ 8 billion in
2015, is expected to reach
has a huge potential for
investments
The market has more than
1,000 players
CRAMS
Source: BMI
36. For updated information, please visit www.ibef.orgPharmaceuticals36
GROWTH IN DRUG SALES
0.8 0.9 1.1 1.3 1.5 2 2 2.70
6.9 8.1 10 11.3 12.6 15.1 18.1 21
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 2009 2010 2011 2012 2013 2014 2015
Patented drugs Generic drugs
Source: BMI
Note: F - Forecast
The share of generic drugs is expected to continue increasing;
domestic generic drug market is expected to reach US$ 27.9 billion in
2020
Due to their competence in generic drugs, growth in this market offers
a great opportunity for Indian firms
Generic drug market is expected to grow in the next few years, with
many drugs going off-patent in the US and other countries
Domestic generic drug market has reached US$ 26.1 billion in 2016
In April 2017, Jubiliant Life Sciences received a final approval from
the US health regulator for olmesartan medoxomil tablets, which is
used for the treatment of hypertension. The approved product is a
generic version of Benicar of Daiichi Sankyo.
Visakhapatnam port traffic (million tonnes)
Share of patented and generic drugs in prescribed drug market
(US$ billion)
38. For updated information, please visit www.ibef.orgPharmaceuticals38
SUN PHARMA: LEVERAGING ITS GENERICS MARKET
CAPABILITIES
932
847
1256
1672
2067
2655
4526
4240
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
2009 2010 2011 2012 2013 2014 2015 2016
Source: Sun Pharma website
Note: Compound Annual Growth Rate
Sun Pharma was set up in 1983, with a compact manufacturing
facility for tablets and capsules
It set up its 1st API plant at Panoli in 1995
It has 48 manufacturing facilities across 5 continents and employs
more than 30,0000 people as on FY16
Nearly 74 per cent of its sales came from international markets in
2016
Revenues of Sun Pharma increased from US$ 932 million in FY09 to
US$ 4.2 billion in FY16, witnessing growth at a CAGR of 24.16 per
cent over FY09-16
In March 2015, Sun Pharma completed the acquisition of Ranbaxy
Laboratories Ltd to become the 5th largest global specialty pharma
company, No 1 pharma company in India, and ensure a strong
positioning in emerging markets
The company reported net profit of US$ 335.8 million for the period
July2016 - September 2016
As of October 2016, the company acquired 100 per cent equity in the
US-based eye care specialist ‘Ocular Technologies Sarl ‘for US$ 40
million
Visakhapatnam port traffic (million tonnes)Sun Pharma net sales (US$ million)
CAGR 24.16%
39. For updated information, please visit www.ibef.orgPharmaceuticals39
DR REDDY’S: PROVIDING AFFORDABLE AND
INNOVATIVE HEALTHCARE
1479
1480
1626
2016
2141
2193
2452
2350
0
500
1000
1500
2000
2500
3000
2009 2010 2011 2012 2013 2014 2015 2016
Source: : Dr Reddy’s website,
Note: FY16* (April to September 2015) CAGR - Compound Annual Growth Rate, RandD – Research and Development
Dr Reddy’s began as an API manufacturer in 1984, producing high-
quality APIs for the Indian domestic market.
It has presence in almost all therapeutic segments.
It has an integrated business model in three segments:
Pharmaceutical Services and Active Ingredients (PSAI), Global
generics and Proprietary products.
Dr Reddy’s has access to numerous emerging markets through
partnerships with GlaxoSmithKline (GSK).
Its product offering spans the entire value chain, from process
development of APIs to submission of the finished dosage dossier to
regulatory agencies.
The company’s revenues increased from US$ 1.5 billion in FY09 to
US$ 2.4 billion in FY16, at a CAGR of 6.84 per cent over FY09-16.
Dr Reddy’s is investing heavily on RandD to differentiate itself in the
market. In FY15 - 16 Dr Reddy’s spent around 13.8 per cent of sales
on RandD.
Visakhapatnam port traffic (million tonnes)Dr Reddy’s net sales (US$ million)
CAGR 6.84%
40. For updated information, please visit www.ibef.orgPharmaceuticals40
LUPIN: ON A HIGH GROWTH PATH
822.5
1006.7
1250.9
1484.6
1742
1839
2090
2093
0
500
1000
1500
2000
2500
2009 2010 2011 2012 2013 2014 2015 2016
Source: : Lupin website
Note: CAGR - Compound Annual Growth Rate, API - Active Pharmaceutical Ingredient, CNS - Central Nervous System, NSAIDS - Non-Steroidal Anti-inflammatory Drugs, TB -
Tuberculosis
Lupin is a renowned pharma player producing a wide range of quality,
affordable generic and branded formulations and APIs
Lupin is the seventh largest generic pharmaceutical company globally
in terms of market capitalisation
Its revenues increased from US$ 822.5 million in FY09 to US$ 2.1
billion in FY16, at a CAGR of 14.3 per cent during FY09-16
Advanced market formulations comprised nearly 46 per cent of its
revenues in FY16
Lupin is 3rd largest drug manufacturer in India by sales
In 2016, Lupin received USFDA nod for its generic version of
Diclofenac capsules that are used for treating acute pain and
osteoarthritis
In February 2017, Lupin has received the final approval from USFDA
to market potassium sulfate, sodium sulfate and magnesium sulfate
oral solutions, which are used to treat a form of cancer.
In March 2017, Lupin received an approval from United States Food
and Drug Administration (US FDA) to market generic version of
tobramycin inhalation solution ‘Tobi’, which is useful to treat cystic
fibrosis patients along with P. aeruginosa.
Visakhapatnam port traffic (million tonnes)Lupin net sales (US$ million)
CAGR 14.3%
42. For updated information, please visit www.ibef.orgPharmaceuticals42
INDUSTRY ORGANISATIONS
Address: Kalina, Santacruz (E),
Mumbai – 400 098
Phone: 91-22-2667 1072
Fax: 91 22 2667 0744
E-mail: ipacentre@ipapharma.org
www.ipapharma.org
The Indian Pharmaceutical Association
Address: 102-B, Poonam Chambers, Dr A.B. Road
Worli, Mumbai – 400 018
Phone: 91-22-2494 4624/2497 4308
Fax: 9122 24950723
E-mail: idma1@idmaindia.com
www.idma-assn.org
Indian Drug Manufacturers' Association
Address: Peninsula Chambers, Ground Floor,
Ganpatrao Kadam Marg, Lower Parel,
Mumbai – 400 013
Phone: 9122 24918123, 24912486, 66627007
Fax: 9122 24915168
E-mail: indiaoppi@vsnl.com
www.indiaoppi.com
Organisation of Pharmaceutical Producers of India
Address: C-25, Industrial Estate, Sanath Nagar
Hyderabad – 500018
Phone: 91 40 23703910/23706718
Fax: 91 40 23704804
E-mail: info@bdmai.org
www.bdmai.org
Bulk Drug Manufacturers Association
43. For updated information, please visit www.ibef.orgPharmaceuticals43
GLOSSARY
CRAMS: Contract Research and Manufacturing Services
API: Active Pharmaceutical Ingredients
FDI: Foreign Direct Investment
GOI: Government of India
INR: Indian Rupee
US$ : US Dollar
BPL: Below Poverty Line
RSBY: Rashtriya Swastha Bima Yojna
ESIC: Employees State Insurance Corporation
Wherever applicable, numbers have been rounded off to the nearest whole number
44. For updated information, please visit www.ibef.orgPharmaceuticals44
EXCHANGE RATES
Year INR Equivalent of one US$
2004–05 44.81
2005–06 44.14
2006–07 45.14
2007–08 40.27
2008–09 46.14
2009–10 47.42
2010–11 45.62
2011–12 46.88
2012–13 54.31
2013–14 60.28
2014-15 61.06
2015-16 65.46
2016-17 66.95
Year INR Equivalent of one US$
2005 43.98
2006 45.18
2007 41.34
2008 43.62
2009 48.42
2010 45.72
2011 46.85
2012 53.46
2013 58.44
2014 61.03
2015 64.15
2016 67.22
Exchange Rates (Fiscal Year) Exchange Rates (Calendar Year)
Source: Reserve bank of India, Average for the year
45. For updated information, please visit www.ibef.orgPharmaceuticals45
DISCLAIMER
India Brand Equity Foundation (IBEF) engaged Aranca to prepare this presentation and the same has been prepared by Aranca in consultation
with IBEF.
All rights reserved. All copyright in this presentation and related works is solely and exclusively owned by IBEF. The same may not be reproduced,
wholly or in part in any material form (including photocopying or storing it in any medium by electronic means and whether or not transiently or
incidentally to some other use of this presentation), modified or in any manner communicated to any third party except with the written approval
of IBEF.
This presentation is for information purposes only. While due care has been taken during the compilation of this presentation to ensure that the
information is accurate to the best of Aranca and IBEF’s knowledge and belief, the content is not to be construed in any manner whatsoever as a
substitute for professional advice.
Aranca and IBEF neither recommend nor endorse any specific products or services that may have been mentioned in this presentation and nor do
they assume any liability or responsibility for the outcome of decisions taken as a result of any reliance placed on this presentation.
Neither Aranca nor IBEF shall be liable for any direct or indirect damages that may arise due to any act or omission on the part of the user due to any
reliance placed or guidance taken from any portion of this presentation.